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1. Introduction {#advs1385-sec-0010}
===============

Hydrogen sulfide (H~2~S) is a highly toxic gas known for its causticity, flammability and distinct odor of rotten eggs.[1](#advs1385-bib-0001){ref-type="ref"}, [2](#advs1385-bib-0002){ref-type="ref"}, [3](#advs1385-bib-0003){ref-type="ref"} However, endogenous H~2~S is the third major gasotransmitter in addition to carbon monoxide (CO) and nitric oxide (NO).[4](#advs1385-bib-0004){ref-type="ref"}, [5](#advs1385-bib-0005){ref-type="ref"}, [6](#advs1385-bib-0006){ref-type="ref"} The misregulation of this signaling molecule is associated with numerous diseases, such as Alzheimer\'s disease, diabetes, and cancer.[7](#advs1385-bib-0007){ref-type="ref"}, [8](#advs1385-bib-0008){ref-type="ref"} Since H~2~S has such a crucial role, an effective H~2~S detection method would facilitate the understanding of the implicated diseases permit early diagnosis. Currently, the most‐used techniques include high‐pressure liquid/gas chromatography (HPLC/GC) have shown significant sensitivity. However, the high cost and tediously processing time severely restrict their practical application in detecting H~2~S in biological samples, especially for real‐time measurements. In comparison, novel small molecules ranging from colorimetric and fluorescent probes have demonstrated substantial advantages for dynamic and in situ H~2~S sensing/imaging via various chemical strategies.[9](#advs1385-bib-0009){ref-type="ref"} Several fluorescent probes, such as sulfidefluor‐1/2 (SF‐1/2) and hydrogen sulfide imaging probe‐1 (HSip‐1) present desirable selectivity and can "turn on" an H~2~S‐activated fluorescent signal for H~2~S detection (e.g., living cell imaging), with limits of detection (LOD) (all the abbreviations could be found in **Table** [**1**](#advs1385-tbl-0001){ref-type="table"}) reported around 5 × 10^−6^--10 × 10^−6^ [m]{.smallcaps}.[10](#advs1385-bib-0010){ref-type="ref"}, [11](#advs1385-bib-0011){ref-type="ref"}, [12](#advs1385-bib-0012){ref-type="ref"} While well‐designed small molecule probes have been applied for H~2~S‐selective detection in live cells and in vivo imaging,[13](#advs1385-bib-0013){ref-type="ref"}, [14](#advs1385-bib-0014){ref-type="ref"} they still present issues such as the relatively low sensitivity and selectivity, poor water solubility, weak fluorescent intensity,[13](#advs1385-bib-0013){ref-type="ref"} and poor circulation (e.g., the accumulation in liver) that must be overcome.[14](#advs1385-bib-0014){ref-type="ref"}

###### 

Full names and the corresponding abbreviations

  Full name                                                     Abbreviation                       Full name                       Abbreviation
  ------------------------------------------------------------ -------------- --------------------------------------------------- --------------
  3‐mercaptopyruvate sulfotransferase                              3‐MST                     Myocardial infarction                      MI
  Aerosol‐assisted chemical vapor deposition                       AACVD                   Metal‐organic frameworks                    MOF
  Alzheimer\'s Disease                                               AD                   11‐mercaptoundecanoic acid                   MUA
  Anethole dithiolethione                                           ADT                 Mesoporous silica nanoparticles                MSNs
  Aggregation‐induced emission                                      AEI                          Near Infrared                         NIR
  Anethole dithiolethione (ADT)‐loaded magnetic nanoliposome        AMLs                     Noble metal clusters                      NMCs
  Amino‐oxyacetic acid                                              AOAA                         Photoacoustic                          PA
  Adenosine triphosphate                                            ATP                  Positron emission tomography                  PET
  Carbon nanodots                                                  C‐dot                     Photodynamic therapy                      PDT
  Cystathionine β‐synthase                                          CBS                     Polymeric nanoparticles                    PMNs
  Carbon nanotubes                                                  CNTs                    Plasmonic nanoparticles                    PNPs
  Cystathionine γ‐lyase                                             CSE                      Polystyrene sulfonate                     PSS
  Diallyl sulfide                                                   DATS                     Photothermal therapy                      PTT
  Functional graphene sheets                                        FGS                     Reactive oxygen species                    ROS
  Ischemia/reperfusion                                              I/R              S‐adenosyl‐[l]{.smallcaps}‐methionine             SAM
  Inner filter effect                                               IFE            Smart H~2~S‐triggered/therapeutic system            SHTS
  Intercellular adhesion molecule‐1                                ICAM‐1              Tris(2‐chloroisopropyl)phosphate                TCPP
  Limits of detection                                               LOD                 3,3′,5,5′‐tetramethylbenzidine                 TMB
  Liposome nanoparticles                                            LNPs       1‐(10‐mercaptodecyl)‐5‐methylpyrimidine‐2,4‐dione       TSH
  Luminescence/Förster resonance energy transfer                 LRET/FRET               Triphenyltetrazolium chloride                 TTC
  Longitudinal surface plasmon resonance\'s                         LSPR                  Upconverting nanoparticles                  UCNPs
  Vascular cell adhesion molecule‐1                                VCAM‐1                  Upconversion luminescence                   UCL
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During the recent two decades, nanomaterials have drawn substantial global attention.[15](#advs1385-bib-0015){ref-type="ref"}, [16](#advs1385-bib-0016){ref-type="ref"}, [17](#advs1385-bib-0017){ref-type="ref"}, [18](#advs1385-bib-0018){ref-type="ref"}, [19](#advs1385-bib-0019){ref-type="ref"} Due to their desirable physiochemical features (e.g., high biocomparability and stability, large specific surface area, excellent loading efficiency, variable modification, etc.),[20](#advs1385-bib-0020){ref-type="ref"}, [21](#advs1385-bib-0021){ref-type="ref"}, [22](#advs1385-bib-0022){ref-type="ref"} nanomaterials have been widely employed in various biomedical applications in drug delivery, vaccination, imaging, and therapy.[23](#advs1385-bib-0023){ref-type="ref"}, [24](#advs1385-bib-0024){ref-type="ref"}, [25](#advs1385-bib-0025){ref-type="ref"}, [26](#advs1385-bib-0026){ref-type="ref"}, [27](#advs1385-bib-0027){ref-type="ref"}, [28](#advs1385-bib-0028){ref-type="ref"}, [29](#advs1385-bib-0029){ref-type="ref"}, [30](#advs1385-bib-0030){ref-type="ref"}, [31](#advs1385-bib-0031){ref-type="ref"}, [32](#advs1385-bib-0032){ref-type="ref"}, [33](#advs1385-bib-0033){ref-type="ref"} With careful design, nanoplatforms can exceed small molecule probes as ideal sensing agents for rapid, selective, and efficient H~2~S detection.[34](#advs1385-bib-0034){ref-type="ref"}, [35](#advs1385-bib-0035){ref-type="ref"}, [36](#advs1385-bib-0036){ref-type="ref"}, [37](#advs1385-bib-0037){ref-type="ref"} Recently, novel nanoprobes have been developed for H~2~S sensing, which efficiently detect and image hydrogen sulfide via 1) chemical features of the loaded smart fluorophore (e.g., Aziede reduction, metal precipitation and nucleophilic attack),[38](#advs1385-bib-0038){ref-type="ref"}, [39](#advs1385-bib-0039){ref-type="ref"}, [40](#advs1385-bib-0040){ref-type="ref"} 2) change of localized surface plasmon resonance\'s (LSPR),[41](#advs1385-bib-0041){ref-type="ref"}, [42](#advs1385-bib-0042){ref-type="ref"}, [43](#advs1385-bib-0043){ref-type="ref"} 3) variation of absorbance (colorimetric assay),[44](#advs1385-bib-0044){ref-type="ref"} 4) surface metal precipitation,[45](#advs1385-bib-0045){ref-type="ref"}, [46](#advs1385-bib-0046){ref-type="ref"}, [47](#advs1385-bib-0047){ref-type="ref"} 5) change of luminescence/Förster resonance energy transfer (LRET/FRET),[48](#advs1385-bib-0048){ref-type="ref"}, [49](#advs1385-bib-0049){ref-type="ref"}, [50](#advs1385-bib-0050){ref-type="ref"} or 6) electrochemical reaction.[51](#advs1385-bib-0051){ref-type="ref"}, [52](#advs1385-bib-0052){ref-type="ref"}, [53](#advs1385-bib-0053){ref-type="ref"} More importantly, a series of therapeutic strategies (e.g., photothermal therapy and photodynamic therapy, etc.) could be intelligently triggered by the activation of endogenous H~2~S from the targeting area.[54](#advs1385-bib-0054){ref-type="ref"}, [55](#advs1385-bib-0055){ref-type="ref"} Additionally, exogenous H~2~S delivery has been successfully achieved via nanoplatforms, which can induce H~2~S‐mediated gas therapy (via physical damage) or tissue protection (e.g., the heart I/R injury) within the disease regions.[56](#advs1385-bib-0056){ref-type="ref"}, [57](#advs1385-bib-0057){ref-type="ref"} These multifunctional nanoplatforms may generate novel treatments available for various H~2~S‐related diseases.

As such a promising field, smart H~2~S‐triggered/therapeutic system (SHTS)‐based nanomedicine is expected to significantly accelerate the development of disease diagnosis and therapeutic strategy by enhancing accuracy and efficiency. Given the vital role of hydrogen sulfide in biological processes and advantages of nanotechnology, we provide an overview of recent progress in H~2~S detection, imaging and related disease therapy via SHTS‐based nanomedicine (**Figure** [**1**](#advs1385-fig-0001){ref-type="fig"}). Within this review, various nanoagents such as noble metal nanomaterials, metal‐organic framework, copper‐based nanomaterials, and carbon nanodot for H~2~S sensing, different imaging (including fluorescence, localized surface plasmon resonance, upconversion luminescence, near‐infrared, photoacoustic and positron emission tomography imaging) and therapeutic strategies (e.g., the endogenous H~2~S‐triggered therapy or exogenous H~2~S delivery) are summarized. As such, we aim to highlight these powerful nanoprobes in this emerging field and offer an overview for the development of next‐generation of SHTS‐based nanomedicine.

![The H~2~S‐specific detection, imaging, and therapy mediated by the smart H~2~S‐triggered/therapeutic system (SHTS).](ADVS-6-1901724-g001){#advs1385-fig-0001}

2. Roles of H~2~S in Biological Systems {#advs1385-sec-0020}
=======================================

Endogenous H~2~S is mainly produced from cysteine by three enzymes: 3‐mercaptopyruvate sulfotransferase (3‐MST), cystathionine β‐synthase (CBS), and cystathionine γ‐lyase (CSE).[58](#advs1385-bib-0058){ref-type="ref"}, [59](#advs1385-bib-0059){ref-type="ref"}, [60](#advs1385-bib-0060){ref-type="ref"}, [61](#advs1385-bib-0061){ref-type="ref"} The H~2~S generated is a vital gas transmitter that affects various biological and physical functions within the body, ranging from antiinflammation to regulation of neuronal transmission.[62](#advs1385-bib-0062){ref-type="ref"}, [63](#advs1385-bib-0063){ref-type="ref"}, [64](#advs1385-bib-0064){ref-type="ref"}, [65](#advs1385-bib-0065){ref-type="ref"} For instance, it has been reported that H~2~S donors promote the production of ATP and electron transport in mitochondrial.[66](#advs1385-bib-0066){ref-type="ref"} Furthermore, H~2~S is able to protect the cell by attenuating apoptosis.

Thus, it has been widely applied as a novel reagent for preserving organs from ischemia‐reperfusion injury during various surgeries and organ transplantations.[67](#advs1385-bib-0067){ref-type="ref"}, [68](#advs1385-bib-0068){ref-type="ref"}, [69](#advs1385-bib-0069){ref-type="ref"} Also, the increased secretion of endogenously H~2~S is strongly associated with the progress of tumor.[4](#advs1385-bib-0004){ref-type="ref"}, [70](#advs1385-bib-0070){ref-type="ref"}

Notably, the H~2~S generating enzymic system including 3‐MST, CBS, and CSE have been widely identified in many cancer types.[4](#advs1385-bib-0004){ref-type="ref"}, [71](#advs1385-bib-0071){ref-type="ref"} The overexpression of CBS has been particularly reported within various colon and ovarian cancers,[72](#advs1385-bib-0072){ref-type="ref"}, [73](#advs1385-bib-0073){ref-type="ref"} indicating the significant role of H~2~S in promoting tumor development. The hydrogen sulfide derived from cancer cells also promotes tumor growth and proliferation by acting as an autocrine and paracrine factor.[72](#advs1385-bib-0072){ref-type="ref"} After introducing a CBS inhibitor, the growth of colon cancer could be greatly attenuated by efficiently reducing H~2~S generation and inhibiting peritumor angiogenesis.[61](#advs1385-bib-0061){ref-type="ref"} However, the fast catabolism and regulation of this toxic gas show a great challenge for real‐time detection within the tissues.[74](#advs1385-bib-0074){ref-type="ref"} As one of the most dangerous gases, the concentration of H~2~S within the air needs to be monitored as well. While this toxic gas easily noted because of its rotten‐egg smell, the exposure to H~2~S can cause a serial of symptoms including lung irritations (≤20 ppm), damage of eye (300--500 ppm), unconsciousness, or even death (≥700 ppm).[75](#advs1385-bib-0075){ref-type="ref"} Therefore, successful detection/imaging of hydrogen sulfide would be immensely valuable for disease diagnosis and treatment, as well as risk management.

3. H~2~S Detection with SHTS‐Based Nanomedicine {#advs1385-sec-0030}
===============================================

To monitor H~2~S in solutions and air, various nanomaterials have been developed as novel sensors, including noble metal nanoparticles (e.g., Au, Ag, and Au/Ag alloy), metal‐organic frameworks (MOF), copper nanomaterials, carbon nanodots, among others (e.g., ruthenium nanoparticles, etc.). In this section, a series of SHTS‐based nanosensors will be summarized (**Table** [**2**](#advs1385-tbl-0002){ref-type="table"}).

###### 

The nanosized materials as SHTS for H~2~S detection

  Material[^a)^](#advs1385-tbl2-note-0001){ref-type="fn"}                       Nanoparticle                           Size \[nm\]               Mechanism                         Assay                     Sample Phase                        LOD                                     Ref.
  --------------------------------------------------------- ----------------------------------------------------- --------------------- ---------------------------- --------------------------------- ------------------------- ------------------------------------ -------------------------------------------
  Au                                                                               Au NRs                                  ≈60                  Aggregation                 Colorimetry (A730)                 Solution              24 × 10^−6^ [m]{.smallcaps}       [76](#advs1385-bib-0076){ref-type="ref"}
                                                                                   AEAuNPs                             13.3 ± 1.6               Aggregation               Colorimetry (A520/720)               Solution              20 × 10^−6^ [m]{.smallcaps}       [44](#advs1385-bib-0044){ref-type="ref"}
                                                                                  GSH‐AuNP                                 13                   Aggregation               Colorimetry (A700/520)               Solution               3 × 10^−6^ [m]{.smallcaps}       [77](#advs1385-bib-0077){ref-type="ref"}
                                                                              BSA‐AuNCs‐HSIP‐1                             ≈1                   Aggregation           Metal precipitation (I519/I632)          Solution             0.73 × 10^−6^ [m]{.smallcaps}      [78](#advs1385-bib-0078){ref-type="ref"}
                                                                               TSH‐MUA‐ AuNDs                           1.9 ± 0.3             Antiaggregation              Fluorescence (Em510)                Solution              0.5 × 10^−6^ [m]{.smallcaps}      [79](#advs1385-bib-0079){ref-type="ref"}
                                                                                 Cu\@Au NPs                                N/A              Competitive binding           Colorimetry (A650/520)               Solution              0.3 × 10^−6^ [m]{.smallcaps}      [80](#advs1385-bib-0080){ref-type="ref"}
                                                                                 AuS/Au NPs                                N/A                   Reduction                  Colorimetry (A414)                 Solution             0.28 × 10^−6^ [m]{.smallcaps}      [81](#advs1385-bib-0081){ref-type="ref"}
                                                                                  FSN‐AuNRs                        30.8 ± 2 × 12.5 ± 1          Aggregation               Colorimetry (A518/A648)           Solution, Serum          0.2 × 10^−6^ [m]{.smallcaps}      [82](#advs1385-bib-0082){ref-type="ref"}
                                                                                   Au NPs                               8.1 ± 1.1                 Catalyst                  Colorimetry (A652)                 Solution              80 × 10^−9^ [m]{.smallcaps}       [83](#advs1385-bib-0083){ref-type="ref"}
                                                                                   Au NPs                                  13                 Antiaggregation               Colorimetry (A520)                Bubble gas             30 × 10^−9^ [m]{.smallcaps}       [84](#advs1385-bib-0084){ref-type="ref"}
                                                                                 Au\@TPt‐NCs                              17.1                    Catalyst                  Colorimetry (A650)          Solution/Evaporated gas      7.5 × 10^−9^ [m]{.smallcaps}      [85](#advs1385-bib-0085){ref-type="ref"}
  Au/Ag                                                                    Core--shell Au\@Ag NCs                         ≈1.8           Quench of the fluorescence        Fluorescence (Em650)                Solution             0.31 × 10^−6^ [m]{.smallcaps}      [86](#advs1385-bib-0086){ref-type="ref"}
                                                                                DNA‐Au/Ag NCs                              1.6           Quench of the fluorescence        Fluorescence (Em440)                Solution             0.83 × 10^−9^ [m]{.smallcaps}      [87](#advs1385-bib-0087){ref-type="ref"}
  Ag                                                                             C314‐Ag NPs                              6--14                  Reduction                 Fluorescence (Em493)                Solution                        ≈60 ppb                 [88](#advs1385-bib-0088){ref-type="ref"}
                                                                                 Chit‐AgNPs                              9 ± 2.5                LSPR change                 Colorimetry (A404)                 Solution             0.35 × 10^−6^ [m]{.smallcaps}      [42](#advs1385-bib-0042){ref-type="ref"}
                                                                               PPF cage‐AgNPs                            6--8.4                 LSPR change                 Colorimetry (A400)                 Solution              0.2 × 10^−6^ [m]{.smallcaps}      [43](#advs1385-bib-0043){ref-type="ref"}
  MOF                                                                  Eu^3+^/Cu^2+^\@UiO‐66‐(COOH)~2~                   80--100            Metal precipitation          Fluorescence (I615/I393)              Solution             5.45 × 10^−6^ [m]{.smallcaps}      [46](#advs1385-bib-0046){ref-type="ref"}
                                                                               Tb^3+^\@Cu‐MOF                              N/A              Metal precipitation          Fluorescence (I544/I390)              Solution              1.2 × 10^−6^ [m]{.smallcaps}      [89](#advs1385-bib-0089){ref-type="ref"}
                                                             \[\[EuCu(pydc)~2~(ox)~0.5~(H~2~O)~3~·1.5H~2~O\]~2n~           N/A                    Catalyst                 Fluorescence (Em615)             Solution, Serum          130 × 10^−9^ [m]{.smallcaps}      [90](#advs1385-bib-0090){ref-type="ref"}
                                                                            Al‐MIL‐53‐NO~2~ MMMs                         60--80                  Reduction                 Fluorescence (Em466)                Solution             92.31 × 10^−9^ [m]{.smallcaps}     [39](#advs1385-bib-0039){ref-type="ref"}
                                                                             Zr(TBAPy)~5~(TCPP)                           ≈100                   Reduction                 Fluorescence (≈Em440)               Solution                         1 ppb                  [91](#advs1385-bib-0091){ref-type="ref"}
                                                                                  Cu‐SWCNTs                                N/A                   Reduction                   Electrochemistry                  Solution                         5 ppm                  [92](#advs1385-bib-0092){ref-type="ref"}
  Cu                                                                        p‐CuO/*n*‐SnO~2~ NWs                        200 (CuO)          Breakup of pn junction            Electrochemistry                     Gas                           1 ppm                  [93](#advs1385-bib-0093){ref-type="ref"}
                                                                           Quasi‐2D Cu~2~O/SnO~2~                          N/A                   Reduction                   Electrochemistry                     Gas                          0.5 ppm                 [94](#advs1385-bib-0094){ref-type="ref"}
                                                                              Cu~2~O‐WO~3~ NDs                        2--3 (Cu~2~O)              Reduction                   Electrochemistry                     Gas                          300 ppb                 [53](#advs1385-bib-0053){ref-type="ref"}
                                                                               PSS‐PAE‐Cu NCs                              173                  Aggregation                Fluorescence (Em665)                Solution              650 × 10^−9^ [m]{.smallcaps}      [95](#advs1385-bib-0095){ref-type="ref"}
                                                                                 Cu~2~O--FGS                           3 (Cu~2~O)                Reduction                   Electrochemistry                     Gas                           5 ppb                  [52](#advs1385-bib-0052){ref-type="ref"}
                                                                               Cysteine‐Cu NCs                             2.5                  Aggregation                Fluorescence (Em460)                Solution              42 × 10^−9^ [m]{.smallcaps}       [96](#advs1385-bib-0096){ref-type="ref"}
  C‐dot                                                                        CD‐Hg^2+^/Ag^+^                             7.6           Quench of the fluorescence        Fluorescence (Em440)                Solution           0.32/0.43 × 10^−6^ [m]{.smallcaps}   [97](#advs1385-bib-0097){ref-type="ref"}
                                                                                  Ag--C‐dot                                ≈5             Electrochemiluminescence           Electrochemistry                  Solution             0.027 × 10^−6^ [m]{.smallcaps}     [51](#advs1385-bib-0051){ref-type="ref"}
                                                                                     GBR                                   N/A                    Catalyst                  Colorimetry (A652)                 Solution             25.3 × 10^−6^ [m]{.smallcaps}      [98](#advs1385-bib-0098){ref-type="ref"}
                                                                                  PPy/WO~3~                              50--70                  Reduction                   Electrochemistry                  Solution                        100 ppb                 [99](#advs1385-bib-0099){ref-type="ref"}
                                                                                 SnO~2~/rGO                                ≈4                  Chemisorption                 Electrochemistry                     Gas                           43 ppb                 [100](#advs1385-bib-0100){ref-type="ref"}
  Others                                                                         Cyclen‐FPNs                             33--40             Metal precipitation            Fluorescence (Em540)                Solution              2.1 × 10^−6^ [m]{.smallcaps}      [101](#advs1385-bib-0101){ref-type="ref"}
                                                                           Pb^2+^‐MoS~2~ nanosheet                         N/A           Quench of the fluorescence        Fluorescence (Em406)                Solution             0.42 × 10^−6^ [m]{.smallcaps}      [102](#advs1385-bib-0102){ref-type="ref"}
                                                                                 PbO/SiO~2~                              50--100         Quench of the fluorescence        Fluorescence (Em510)                Solution             0.138 × 10^−6^ [m]{.smallcaps}     [103](#advs1385-bib-0103){ref-type="ref"}
                                                                                   Ru NPs                               1.7 ± 0.2                 Catalyst                  Colorimetry (A512)                 Solution              0.6 × 10^−9^ [m]{.smallcaps}      [44](#advs1385-bib-0044){ref-type="ref"}

LSPR: localized surface plasmon resonance; NCs: nanocluster; NRs: nanorods; NDs: nanodots; NWs: nanowires; NNs: nanoneedles.
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3.1. Noble Metal Nanomaterials {#advs1385-sec-0040}
------------------------------

Gold and silver are two major noble metals that have been widely used in daily life for centuries. For instance, colloidal gold is a well‐known dye for glass staining that can be traced back to the Roman era. With the excellent stability, catalytic ability, and optical properties, gold, silver, and alloy nanomaterials have been widely developed and applied for biomedical engineering applications.[43](#advs1385-bib-0043){ref-type="ref"}, [85](#advs1385-bib-0085){ref-type="ref"}, [87](#advs1385-bib-0087){ref-type="ref"} The LSPR is a key characteristic of noble metal nanomaterial that is easily influenced by the size, distance, and composition.[104](#advs1385-bib-0104){ref-type="ref"} Based on this property, a variety of detection methods have been developed by the formation/dispersion of aggregation or change of the surface, including the specific detection for hydrogen sulfide (Table [2](#advs1385-tbl-0002){ref-type="table"}).

With proper surface functionalization using different ligands such as glutathione,[77](#advs1385-bib-0077){ref-type="ref"} fluorosurfactants,[82](#advs1385-bib-0082){ref-type="ref"} or small molecules (e.g., thiolated azido derivates and active esters),[44](#advs1385-bib-0044){ref-type="ref"} gold nanosensors quickly aggregate when they encounter with H~2~S. This results in a redshift of absorbance wavelengths and LOD ranging from 0.2 × 10^−6^ to 20 × 10^−6^ [m]{.smallcaps}. In comparison, hydrophobic surface modification (e.g., fluorescent probe, 1‐(10‐mercaptodecyl)‐5‐methylpyrimidine‐2,4‐dione, TSH) force the AuNDs coated with TSH and MUA (11‐mercaptoundecanoic acid) to aggregate. The presence of H~2~S could disassemble the aggregation surface adsorption of H~2~S and HS, recovering the quantum yield back to 1.61%.[79](#advs1385-bib-0079){ref-type="ref"} Similarly, Zhang et al. developed a simple sensing strategy by using bubbling H~2~S to stabilize the AuNPs (13 nm), with the existence of NaCl (80 × 10^−3^ [m]{.smallcaps}) and Tween 80 (**Figure** [**2**](#advs1385-fig-0002){ref-type="fig"}A).[84](#advs1385-bib-0084){ref-type="ref"} This cost‐effective method provides a high sensitivity toward H~2~S with LOD values reaching around 14 × 10^−6^ [m]{.smallcaps} for the naked eye and 30 × 10^−9^ [m]{.smallcaps} for machine detection, which is more efficient than that afforded by TSH‐MUA‐AuNDs (0.5 × 10^−6^ [m]{.smallcaps}).

![A) The scheme of AuNPs for detecting bubbling H~2~S with the coordination of NaCl and Tween‐80. Reproduced with permission.[86](#advs1385-bib-0086){ref-type="ref"} Copyright 2014, American Chemical Society. B) Schematic demonstration of the Au\@TPt‐NCs‐based platform for detecting dissolved hydrogen sulfide via a colorimetric strategy. C) The deactivated assays of Au\@TPt‐NCs (Au core @ ultrathin platinum shell nanoclusters) via H~2~S (the testing groups included: a) Au\@TPt‐NCs; b) H~2~O~2~ + TMB (3,3′,5,5′‐tetramethylbenzidine); c) 0.1 × 10^−6^ [m]{.smallcaps} H~2~S; d) Au\@TPt‐NCs + H~2~O~2~ + TMB; e) Au\@TPt‐NCs + 0.1 × 10^−6^ [m]{.smallcaps} H~2~S; f) Au\@TPt‐NCs + 0.1 × 10^−6^ [m]{.smallcaps} H~2~S + H~2~O~2~ + TMB; g) Au\@TPt‐NCs + 0.5 × 10^−6^ [m]{.smallcaps} H~2~S + H~2~O~2~ + TMB); h) Au\@TPt‐NCs + 1 × 10^−6^ [m]{.smallcaps} H~2~S + H~2~O~2~ + TMB); D) the detection of H~2~S at various concentrations (a) 0 × 10^−6^ [m]{.smallcaps}; b) 0.1 × 10^−6^ [m]{.smallcaps}; c) 0.2 × 10^−6^ [m]{.smallcaps}; d) 0.5 × 10^−6^ [m]{.smallcaps}) via the catalysis of Au\@TPt‐NCs platform (*n* = 3). Reproduced with permission.[87](#advs1385-bib-0087){ref-type="ref"} Copyright 2015, American Chemical Society. E,F) Schematic illustration of DNA‐Au/Ag NCs Probe\'s synthesis and detection of H~2~S; H~2~S‐induced fluorescent quenching of DNA‐Au/Ag NCs in the presence of S^2−^ ions over G) 0 × 10^−6^ --0.01 × 10^−6^ [m]{.smallcaps} and H) 0.01 × 10^−6^--9 × 10^−6^ [m]{.smallcaps}. Reproduced with permission.[89](#advs1385-bib-0089){ref-type="ref"} Copyright 2011, American Chemical Society.](ADVS-6-1901724-g002){#advs1385-fig-0002}

While other approaches, such as the change of LSPR induced by surface reduction and competitive binding between S‐Au and I‐Au (forming clusters or larger nanoparticles),[80](#advs1385-bib-0080){ref-type="ref"}, [81](#advs1385-bib-0081){ref-type="ref"} have been used with gold‐based sensors, the sensing limits only reach about 0.3 × 10^−6^ [m]{.smallcaps} for H~2~S detection. Comparably, catalysis mediated by Au based nanosensors has excellent sensitivity.[83](#advs1385-bib-0083){ref-type="ref"}, [85](#advs1385-bib-0085){ref-type="ref"} A catalysis Au\@TPt‐NCs (Au core with an ultrathin platinum shell) nanoplatform was developed by Gao et al. to detect dissolved H~2~S gas (Figure [2](#advs1385-fig-0002){ref-type="fig"}B).[85](#advs1385-bib-0085){ref-type="ref"} The H~2~S evaporated or dissolved interacts with and deactivates the nanoclusters, attenuating the chromogenic reaction between H~2~O~2~ and 3,3′,5,5′‐tetramethylbenzidine (TMB) and showing an extremely low LOD value at 7.5 × 10^−9^ [m]{.smallcaps}. More importantly, the approach is also visible to the naked, providing flexibility for applications (Figure [2](#advs1385-fig-0002){ref-type="fig"}C,D).

Additionally, the Au/Ag alloy has also been recruited for sensing H~2~S by fluorescence quenching.[86](#advs1385-bib-0086){ref-type="ref"}, [87](#advs1385-bib-0087){ref-type="ref"} Among all, a sensitive DNA‐templated Au/Ag NCs was successfully developed by Chen et al (Figure [2](#advs1385-fig-0002){ref-type="fig"}E,F).[87](#advs1385-bib-0087){ref-type="ref"} In the presence of H~2~S, the prepared Au/Ag NCs showed a linear relationship (0 × 10^−6^--0.01 × 10^−6^ [m]{.smallcaps} and 0.01 × 10^−6^--9 × 10^−6^ [m]{.smallcaps}) between the H~2~S concentration and fluorescence intensity, with a quantum yield of 4.5% and a LOD of 0.83 × 10^−9^ [m]{.smallcaps} (Figure [2](#advs1385-fig-0002){ref-type="fig"}G,H). Among Ag‐based nanoplatforms, only several polymer‐coating Ag nanoparticles have been investigated and relatively‐low efficiency was demonstrated for H~2~S detection (0.2 × 10^−6^--3.3 × 10^−6^ [m]{.smallcaps}) compared with that provided by Au‐based nanoprobes.[42](#advs1385-bib-0042){ref-type="ref"}, [43](#advs1385-bib-0043){ref-type="ref"}, [88](#advs1385-bib-0088){ref-type="ref"}

3.2. Metal‐Organic Framework (MOF) {#advs1385-sec-0050}
----------------------------------

The past decade has seen drawn a great deal of attention to metal‐organic framework (MOF) due to their excellent physiochemical features.[105](#advs1385-bib-0105){ref-type="ref"}, [106](#advs1385-bib-0106){ref-type="ref"}, [107](#advs1385-bib-0107){ref-type="ref"}, [108](#advs1385-bib-0108){ref-type="ref"}, [109](#advs1385-bib-0109){ref-type="ref"}, [110](#advs1385-bib-0110){ref-type="ref"} These nanomaterials are composed of different combinations of metal ions, organic linkers, and modifications and have vast application possibilities (e.g., gas storage, chemical sensing, chiral separations, etc.).[111](#advs1385-bib-0111){ref-type="ref"} With the tremendous surface area (≈7000 m^2^ g^−1^) and rigid pores that could host various functional molecules, MOF has also been investigated as a potential sensor for chemical and toxic gas detection, such as hydrosulfide.[112](#advs1385-bib-0112){ref-type="ref"} Through the formation of the metal sulfides (e.g., CuS),[46](#advs1385-bib-0046){ref-type="ref"}, [89](#advs1385-bib-0089){ref-type="ref"}, [90](#advs1385-bib-0090){ref-type="ref"} amine group,[39](#advs1385-bib-0039){ref-type="ref"} or N---S bond[91](#advs1385-bib-0091){ref-type="ref"} with S^2−^, several novel MOFs could recover the fluorescence/luminescence that was quenched and trigger a detectable signal for sensing H~2~S with a desirable sensitivity. For instance, the presence of Tb^3+^/Cu^2+^ ions enables the Tb^3+^\@Cu1/Cu2 MOF complex to generate multiwavelength luminescence and produce an enhanced ratiometric signal (*I* ~544~/*I* ~390~) after the interaction with the H~2~S exposed, with a LOD of S^2−^ at about 1.2 × 10^−6^ [m]{.smallcaps}.[89](#advs1385-bib-0089){ref-type="ref"} Similarly, Qian Lab synthesized an Eu^3+^\@UiO‐66‐(COOH)~2~ MOF that induced a fluorescent signal via the interaction between Cu^2+^ and S^2−^.[46](#advs1385-bib-0046){ref-type="ref"} Although such MOF exhibits a uniform nanostructure (80--100 nm) and comparable H~2~S LOD (5.45 × 10^−6^ [m]{.smallcaps}), the fluorescence intensity generated could be affected by amino acids containing thiol and nitroxyl groups, which strongly lowers selectivity toward H~2~S.[46](#advs1385-bib-0046){ref-type="ref"} Comparably, the novel sensors, Zr(TBAPy)~5~(TCPP) and aluminum‐based MOF (Al‐MIL‐53‐NO~2~) demonstrate desirable H~2~S detection and selectivity via reduction, with LOD of ≈92.31 × 10^−9^ [m]{.smallcaps} and ≈1 ppb, respectively.[39](#advs1385-bib-0039){ref-type="ref"}, [91](#advs1385-bib-0091){ref-type="ref"} The Zr(TBAPy)~5~(TCPP) were synthesized with a uniform nanostructure (with a diameter around 100 nm) after incorporation of Tris(2‐chloroisopropyl)phosphate (TCPP) (**Figure** [**3**](#advs1385-fig-0003){ref-type="fig"}A,B).[91](#advs1385-bib-0091){ref-type="ref"} This synthesized nanoparticle was very sensitive to H~2~S (with a LOD around 50 × 10^−9^ [m]{.smallcaps}), and only showed fluorescence after the introduction of H~2~S, demonstrating a desirable linear relation between fluorescence and the concentration of H~2~S (Figure [3](#advs1385-fig-0003){ref-type="fig"}C,D,F). More importantly, the reaction of Zr(TBAPy)~5~(TCPP) and H~2~S was completed within 10 s, providing an opportunity for real‐time detection (Figure [3](#advs1385-fig-0003){ref-type="fig"}E).

![A) Representative TEM and B) HR‐TEM images of Zr(TBAPy)~5~(TCPP); C) The photoluminescence emission spectra among Zr(TBAPy)5(TCPP) (black), NU‐1000 (red), TBAPy (blue), and TCPP (cyan). D) The variation of fluorescence generated by Zr(TBAPy)5(TCPP) with a series of S^2−^ concentrations and E) the change of fluorescence intensity at various time points post the addition of S^2−^ into the Zr(TBAPy)5(TCPP) solution; F) Fluorescence pictures (λ~ex~ = 365 nm) of Zr(TBAPy)5(TCPP) aqueous solutions with different anions. Reproduced with permission.[93](#advs1385-bib-0093){ref-type="ref"} Copyright 2018, Wiley.](ADVS-6-1901724-g003){#advs1385-fig-0003}

As alternatives to single substrate MOFs, probes for the detection of multiple biomolecules are highly desirable for large scale detection in environmental or clinical assay. Recently, a Eu^3+^‐Cu^2+^ based MOF was developed.[90](#advs1385-bib-0090){ref-type="ref"} With two specific and separate binding areas for ascorbic acid (AA) and H~2~S, it simultaneously detected both biomolecules. Due to the high sensitivities, the as‐prepared MOF can identify H~2~S and AA concentrations as lower as 130 × 10^−9^ and 55 × 10^−9^ [m]{.smallcaps}, respectively. Additionally, desirable recovery rate (94.7--104.1%) was attained in assays using human serum. After incorporating various elements and molecules, novel MOF‐based probes for multiple biomolecule detection have significant promise for biomedical applications.

3.3. Copper Based Nanomaterials {#advs1385-sec-0060}
-------------------------------

Copper (Cu), the most‐used cation for H~2~S sensing (via the metal precipitation), has been widely incorporated into small organic molecules (e.g., HSIP‐1) and the other nanosized probes.[78](#advs1385-bib-0078){ref-type="ref"}, [80](#advs1385-bib-0080){ref-type="ref"} The addition of Cu to nanomaterials in the form of Cu, CuO, or Cu~2~O is also employed for H~2~S‐specific detection.[52](#advs1385-bib-0052){ref-type="ref"} Coating the surface of nanoparticle sensors (e.g., nanowires, nanoneedles, or nanotubes) with Cu, CuO, or Cu~2~O enables rapid detection of H~2~S due to variations in conductivity after reduction. As such, the concentration of H~2~S in the solution or air can be determined.[53](#advs1385-bib-0053){ref-type="ref"}, [92](#advs1385-bib-0092){ref-type="ref"}, [93](#advs1385-bib-0093){ref-type="ref"} For example, a Cu~2~O NPs (2--3 nm) coated WO~3~ nanoneedles were prepared via aerosol‐assisted chemical vapor deposition (AACVD).[53](#advs1385-bib-0053){ref-type="ref"} This system was able to detect H~2~S levels as low as 300 ppb within two seconds. A major limitation of the Cu~2~O‐WO~3~ nanoneedles was the high temperature required (390 °C) that makes practical application difficult. A Quasi‐2D‐Cu~2~O/SnO~2~ consisting of P‐type Cu~2~O and N‐type SnO~2~ was successfully developed for H~2~S gas detection at room temperature, with a LOD at 0.5 ppm.[94](#advs1385-bib-0094){ref-type="ref"} Notably, laser illumination further reduced the heterojunction barrier and enhanced the response of Quasi‐2D‐Cu~2~O/SnO~2~ by 20%. The Chen lab synthesized a Cu~2~O‐FGS (functional graphene sheets) by in situ growth that provided desirable surface accessibility, contacting area (Cu~2~O was prepared without surfactant) and sensitivity (LOD is around 5 ppb) for H~2~S gas sensing under normal atmospheric conditions (**Figure** [**4**](#advs1385-fig-0004){ref-type="fig"}A--C).[52](#advs1385-bib-0052){ref-type="ref"}

![A) Schematic demonstrating the in situ approach for synthesizing the Cu~2~O‐FGS (functional graphene sheets) platform; B) Representative SEM image of the Cu~2~O--FGS established on the Si/SiO~2~ substrate with gold interdigitated electrodes coverage; C) Sensitivity limits of Cu~2~O--FGS and FGS based detector in series of concentrations of atmospheric H~2~S. Reproduced with permission.[52](#advs1385-bib-0052){ref-type="ref"} Copyright 2013, Royal Society of Chemistry. D) Schematic illustration of the polystyrene sulfonate (PSS) mediated PSS‐PAE‐Cu NC synthesis. E) Optical images of PSS‐PAE‐Cu NC aggregates prepared via various concentrations of PSS (0.005--0.5 wt%) without (upper row) and with UV illumination; F) The photoluminescence spectra of the PSS‐PAE‐Cu NC aggregates under various concentrations of H~2~S and the linear relationship between the photoluminescent intensity of PSS‐PAE‐Cu NC aggregates and the concentration of H~2~S with sodium phosphate buffer (10 × 10^−3^ [m]{.smallcaps}, pH 3.0). Reproduced with permission.[97](#advs1385-bib-0097){ref-type="ref"} Copyright 2016, Nature Research.](ADVS-6-1901724-g004){#advs1385-fig-0004}

Several studies have confirmed that the aggregation of organic Cu NCs (e.g., cysteine or penicillamine (PAE) template) can activate an enhanced fluorescence referred to as aggregation‐induced emission (AIE).[95](#advs1385-bib-0095){ref-type="ref"}, [96](#advs1385-bib-0096){ref-type="ref"} By incorporating polystyrene sulfonate (PSS) into the system, PSS‐PAE‐Cu NCs aggregates were designed H~2~S detection in drinking water (Figure [4](#advs1385-fig-0004){ref-type="fig"}D).[95](#advs1385-bib-0095){ref-type="ref"} With the 0.05 wt% PSS, as‐prepared PSS‐PAE‐Cu NCs aggregates (173 nm) generated red photoluminescence (665 nm) that was extinguished when as little as 650 × 10^−9^ [m]{.smallcaps} H~2~S was present (Figure [4](#advs1385-fig-0004){ref-type="fig"}E,F).

3.4. Carbon Nanodot {#advs1385-sec-0070}
-------------------

Since the first discovery at 2004, carbon nanodots (C‐dots or CDs) have been widely investigated for biomedical, catalytic, and sensing applications due to its attractive features of high solubility, biocompatibility, and photostability.[113](#advs1385-bib-0113){ref-type="ref"}, [114](#advs1385-bib-0114){ref-type="ref"}, [115](#advs1385-bib-0115){ref-type="ref"} Among all, several novel C‐dots have been designed for H~2~S detection/imaging.[51](#advs1385-bib-0051){ref-type="ref"}, [97](#advs1385-bib-0097){ref-type="ref"}, [116](#advs1385-bib-0116){ref-type="ref"}, [117](#advs1385-bib-0117){ref-type="ref"} For example, two metal ion (Ag^+^/Hg^+^) based C‐dots were synthesized for sensing sulfide ions. In the presence of H~2~S as low as 0.32 × 10^−6^ and 0.43 × 10^−6^ [m]{.smallcaps} respectively, the fluorescence of CD‐Hg^+^/Ag^+^ would be quenched by the inner filter effect (IFE) mediated by the Hg~2~S/Ag~2~S formed. Meanwhile, the formation of Ag~2~S significantly changes the Ag--C‐dot\'s electrochemiluminescence that shows a desirable sensitivity with a LOD at 27 × 10^−9^ [m]{.smallcaps}.[56](#advs1385-bib-0056){ref-type="ref"}, [57](#advs1385-bib-0057){ref-type="ref"}

3.5. Other Nanosensors {#advs1385-sec-0080}
----------------------

Other nanomaterials such as Pb‐based NPs, graphene supporting and polymeric nanocomposites, and ruthenium NPs have been investigated as nanosensors for H~2~S detection (Table [2](#advs1385-tbl-0002){ref-type="table"}).[44](#advs1385-bib-0044){ref-type="ref"}, [98](#advs1385-bib-0098){ref-type="ref"}, [99](#advs1385-bib-0099){ref-type="ref"}, [100](#advs1385-bib-0100){ref-type="ref"}, [101](#advs1385-bib-0101){ref-type="ref"}, [102](#advs1385-bib-0102){ref-type="ref"}, [103](#advs1385-bib-0103){ref-type="ref"} Given the great conductivity of graphene, a SnO~2~‐rGO (reduced graphene oxide) nanosheet was successfully developed via a one‐step colloidal synthesis for H~2~S sensing (**Figure** [**5**](#advs1385-fig-0005){ref-type="fig"}A).[100](#advs1385-bib-0100){ref-type="ref"} H~2~S gas was adsorbed (i.e., chemisorption) and detected within 2 s at room temperature with a desirable sensitivity (with LOD at 43 ppb) (Figure [5](#advs1385-fig-0005){ref-type="fig"}B,C). Two polymeric nanoparticles, the PPy/WO~3~ (50--70 nm) and cyclen‐FPNs (33--40 nm) were designed for identifying this gas as well.[99](#advs1385-bib-0099){ref-type="ref"}, [101](#advs1385-bib-0101){ref-type="ref"} After electrochemical electron transfer (i.e., H~2~S + 3O~2~ ^−^ → 2H~2~O + 2SO~2~ + 3e^−^) and the formation of CuS (i.e., the recovery of fluorescence), H~2~S concentrations could be well determined by PPy/WO3 and cyclen‐FPNs (Table [2](#advs1385-tbl-0002){ref-type="table"}). Recently, Zhao et al. developed a colorimetric approach via the catalysts mediated by ruthenium nanoparticles (Ru NPs) (Figure [5](#advs1385-fig-0005){ref-type="fig"}D).[44](#advs1385-bib-0044){ref-type="ref"} The synthesized Ru NPs (1.7 ± 0.2 nm) degraded the organic dye---Orange I. The resulting color fade occured about 4, 47, and 165 times faster than for platinum (Pt), iridium (Ir) based NPs, and control groups. Exposure of the Ru NPs and Orange I to H~2~S protected the Orange I by deactivating Ru NPs (Figure [5](#advs1385-fig-0005){ref-type="fig"}E). The superior catalytic capability of Ru NPs demonstrated an excellent LOD (about 0.6 × 10^−9^ [m]{.smallcaps}), but it had a relatively poor selectivity to H~2~S as cross‐reaction with Cys and GSH occurred (Figure [5](#advs1385-fig-0005){ref-type="fig"}F).[44](#advs1385-bib-0044){ref-type="ref"}

![A) Representative HR‐TEM images of SnO~2~/rGO nanocomposites and the electron diffraction pattern within the selected area. B) The selective capability of SnO~2~/rGO nanocomposites for detecting H~2~S gas among various interference. C) The response rate of SnO~2~/rGO nanocomposites under different H~2~S gas concentrations. Reproduced with permission.[102](#advs1385-bib-0102){ref-type="ref"} Copyright 2016, American Chemical Society. D) Schematic demonstrating the Ru NPs‐based colorimetric assay for H~2~S detection via the hydrogenation catalysis. E) The change of constant rate under various concentrations of Na~2~S (5 × 10^−9^--100 × 10^−9^ [m]{.smallcaps}), the H~2~S donor. F) The different absorbance intensities (512 nm) of Ru‐NPs and orange I mixtures with various biological thiols and other amino acids attendance, and corresponding optical images of samples within 2 min (inserted figure). Reproduced with permission.[44](#advs1385-bib-0044){ref-type="ref"} Copyright 2017, American Chemical Society.](ADVS-6-1901724-g005){#advs1385-fig-0005}

4. H~2~S Imaging with SHTS‐Based Nanomedicine {#advs1385-sec-0090}
=============================================

As we have mentioned, micro‐ or nano‐probes have been widely applied for H~2~S measurements in clinical samples and has greatly facilitated bench efforts. However, the real‐time imaging of H~2~S secretion in patients for disease diagnosis, especially tumor tracking, is still highly demanded. Among all the in vitro and in vivo imaging candidates, nanocarriers have shown great potential as fluorescent, LSPR, upconversion luminescence (UCL), near infrared (NIR), photoacoustic (PA) and positron emission tomography (PET) imaging probes (**Table** [**3**](#advs1385-tbl-0003){ref-type="table"}). In comparison with the fluorescence and UCL imaging, only a few of nanoprobes has been used for H~2~S imaging via NIR, LSRP, PA, and PET. These nanosensors would be described in detail in this section.

###### 

The novel nanosensors as SHTS for H~2~S imaging

  Imaging strategy[^a)^](#advs1385-tbl3-note-0001){ref-type="fn"}     Material               Nanoparticles              Size \[nm\]            Mechanism                       Assay                             Sample(s)                                       LOD                                        Ref.
  ----------------------------------------------------------------- ------------ ------------------------------------- ------------- ------------------------------ --------------------------- -------------------------------------------- ------------------------------------------- -------------------------------------------
  FL                                                                    MOF                 UiO‐66‐CH = CH2               20--30           Reduction (C = C)                 Em ≈ 370                            PC‐12 cell                         6.46 × 10^−6^ [m]{.smallcaps}         [120](#advs1385-bib-0120){ref-type="ref"}
                                                                                  \[Al(OH)(IPA‐N3)\]·3.2 H~2~O·0.4DMF       N/A                Reduction                       Em405                            J774A.1 cell                        2.65 × 10^−6^ [m]{.smallcaps}         [121](#advs1385-bib-0121){ref-type="ref"}
                                                                                            CuO\@TO\@UiO‐66                 N/A       FRET interruption (Turn‐off)           Em520‐650                      A549 and HepG2 cell                     0.51 × 10^−6^ [m]{.smallcaps}         [45](#advs1385-bib-0045){ref-type="ref"}
                                                                       C‐dot              C‐Dot‐Ligand‐Cu^2+^               ≈5            Metal precipitation                  Em455                         HeLa and L929 cell                     0.78 × 10^−6^ [m]{.smallcaps}         [117](#advs1385-bib-0117){ref-type="ref"}
                                                                                          C‐Dot‐TPEA--Cu^2+^                ≈5            Metal precipitation                  Em560                   Hela cell and A549 tumor slide               0.7 × 10^−6^ [m]{.smallcaps}          [116](#advs1385-bib-0116){ref-type="ref"}
                                                                                           Cyclam‐CDs (CCDs)                ≈2            Metal precipitation                  Em460                             Hela cell                          130 × 10^−9^ [m]{.smallcaps}          [122](#advs1385-bib-0122){ref-type="ref"}
                                                                                              FCDs‐Cu^2+^                    4            Metal precipitation                  Em452                             Hela cell                          88.9 × 10^−9^ [m]{.smallcaps}         [40](#advs1385-bib-0040){ref-type="ref"}
                                                                                            CD‐based sensor                 ≈5          FRET induction (Turn‐on)             I526/I425                       HeLa and L929 cell                      10 × 10^−9^ [m]{.smallcaps}          [50](#advs1385-bib-0050){ref-type="ref"}
                                                                       Other                 FAM‐DNA/AgNP                 10 ± 3               Reduction                       Em520                             Hela cell                           10 × 10^−9^ [m]{.smallcaps}          [47](#advs1385-bib-0047){ref-type="ref"}
                                                                                              NanoBODIPY                    ≈10       FRET interruption (Turn‐on)              Em589                           Raw 264.7 cell                        7 × 10^−9^ [m]{.smallcaps}           [49](#advs1385-bib-0049){ref-type="ref"}
  LSPR                                                                 Au/Ag                  Au/Ag PNPs                   74.19               LSPR shift            A702 (Dark field imaging)              HepG2 and Hela cell                     0.1 × 10^−6^ [m]{.smallcaps}          [41](#advs1385-bib-0041){ref-type="ref"}
  UCL                                                                  UCNPs                   Cy7‐UCNPs                11.27--44.6   LRET interruption (Turn‐on)              Em800                  Hela and MCF‐7 cell; Zebra fish               510 × 10^−9^ [m]{.smallcaps}          [123](#advs1385-bib-0123){ref-type="ref"}
                                                                                           TPAMC‐UCNPs\@PEG                 ≈35       LRET interruption (Turn‐on)            I530/I660              Hela and MCF‐7; HCT‐116 bearing mice            0.22 × 10^−6^ [m]{.smallcaps}         [48](#advs1385-bib-0048){ref-type="ref"}
                                                                                     NaYF4: 20% Yb, 2% Er, 0.2% Tm          94        LRET interruption (Turn‐on)         I~green~/I~red~                        Hela cell                          0.58 × 10^−6^ [m]{.smallcaps}         [124](#advs1385-bib-0124){ref-type="ref"}
                                                                                             CHC~1~‐UCNPs                   24        LRET interruption (Turn‐on)       *I* ~541~/*I* ~800~               Hela cell and Mice (LPS)                  0.13 × 10^−6^ [m]{.smallcaps}         [125](#advs1385-bib-0125){ref-type="ref"}
                                                                                          PAA‐NaYF 4:Yb/Er/Tm               12        LRET interruption (Turn‐on)     I540/I800 or I650/I800                     Hela cell                                       N/A                      [34](#advs1385-bib-0034){ref-type="ref"}
  NIR                                                                  Silica                   ZX‐NIR                      ≈66        Nucleophilic substitution            Em900‐1300           HepG2, HCT‐116 cell and tumor‐bearing mice         ≈37 × 10^−9^ [m]{.smallcaps}          [126](#advs1385-bib-0126){ref-type="ref"}
  PA                                                                   Silica                Si\@BODPA180                   ≈75        Nucleophilic substitution               ex780                        HCT‐116 bearing mice                     53 × 10^−9^ [m]{.smallcaps}          [38](#advs1385-bib-0038){ref-type="ref"}
                                                                      Liposome                  AzHD‐LP                     ≈12                Reduction                       ex700               HCT‐116 cells and HCT‐116 bearing mice            91 × 10^−9^ [m]{.smallcaps}          [127](#advs1385-bib-0127){ref-type="ref"}
  PET                                                                ^64^Cu^2+^              ^64^Cu‐cyclen                  N/A           Metal precipitation                   PET                             Mice and Rat                  0.15 × 10^−6^ [m]{.smallcaps} (≈1% g^−1^)   [128](#advs1385-bib-0128){ref-type="ref"}

FL: fluorescence; UCL: Upconversion luminescence; NIR: Near infrared; PA: photoacoustic imaging; PET: positron emission tomography.

John Wiley & Sons, Ltd.

4.1. Fluorescence Imaging {#advs1385-sec-0100}
-------------------------

With the innovation of imaging technology, two‐ and multiphoton microscopy has been used for fluorescence imaging, which greatly improved the depth of penetration (≈1 mm).[118](#advs1385-bib-0118){ref-type="ref"}, [119](#advs1385-bib-0119){ref-type="ref"} However, most fluorescent agents have generally employed for living cell or tissue section based imaging. For instance, the incorporation of organic components (azide or unsaturated C=C bond) enabled MOF to be used for specific imaging in a series of cancer cell lines (e.g., PC12 and J774A.1 cells) via reduction mediated by H~2~S.[120](#advs1385-bib-0120){ref-type="ref"}, [121](#advs1385-bib-0121){ref-type="ref"} Comparably, further functionalization with Cu^2+^ based ligands (e.g., Cyclam‐Cu^2+^) enabled the C‐Dots to visualize H~2~S within cells via fluorescence initiated after CuS precipitation.[40](#advs1385-bib-0040){ref-type="ref"}, [116](#advs1385-bib-0116){ref-type="ref"}, [117](#advs1385-bib-0117){ref-type="ref"}, [122](#advs1385-bib-0122){ref-type="ref"} These nanosensors demonstrated desirable biocompatibility and efficiently detected H~2~S in Hela or L929 cells, with LOD ranging from around 90 × 10^−9^--780 × 10^−9^ [m]{.smallcaps}. Notably, C‐Dot‐TPEA--Cu^2+^, a two‐photon nanoprobe, exhibited excellent tumor penetration that could be used for sensing H~2~S in A549 tumor sections. This system provided an emission wavelength (560 nm) suitable to minimize background for H~2~S and nuclei imaging, compared with those (≈460 nm) offered by other C‐dots.[116](#advs1385-bib-0116){ref-type="ref"}

Internal Förster resonance energy transfer (FRET) is able to aid specific imaging of H~2~S in vivo. The FRET acceptor (e.g., CuO coated on the surface) or probe structure changes could initiate or terminate FRET in response to H~2~S.[45](#advs1385-bib-0045){ref-type="ref"}, [49](#advs1385-bib-0049){ref-type="ref"}, [50](#advs1385-bib-0050){ref-type="ref"} Notably, carried fluorophores can change its excitation or emission wavelength to act as the imaging trigger when exposed to H~2~S.[49](#advs1385-bib-0049){ref-type="ref"} For instance, boron‐dipyrromethene (BODIPY), with a small Stokes shift and high fluorescent quantum yields, has been widely employed in various nanosized platforms for probing H~2~S. A micellar nanomaterial was designed by incorporating an amphiphilic copolymer (mPEGDSPE), semi‐cyanine‐BODIPY hybrid dye (BODInDCI), and BODIPY1 as the energy donor for H~2~S imaging. (**Figure** [**6**](#advs1385-fig-0006){ref-type="fig"}A).[49](#advs1385-bib-0049){ref-type="ref"} Once the BODInDCl was exposed to H~2~S, its absorption wavelength rapidly shifted from 540 to 738 nm and suspend FRET between it and BODIPY1, eventually recovering and switching off fluorescence at 511 and 589 nm (Figure [6](#advs1385-fig-0006){ref-type="fig"}B). Importantly, this reaction was quickly finished within 140 s, demonstrating high efficiency for H~2~S detection.[129](#advs1385-bib-0129){ref-type="ref"} Additionally, this nanoBODIPY probe was able to track endogenous H~2~S in a macrophage cell line (RAW 264.7) based on the ratio between the dual‐color images (Figure [6](#advs1385-fig-0006){ref-type="fig"}C,D).[49](#advs1385-bib-0049){ref-type="ref"}

![A) Schematic interpretation of FRET between the responsive energy acceptor (BODInD‐Cl, red star) and the complementary energy donor (BODIPY1, green star) in the NanoBODIPY micellar aggregate. B) The fluorescence spectra of the NanoBODIPY under different concentrations of NaHS (0 × 10^−6^ to 10.0 × 10^−6^ [m]{.smallcaps}); confocal microscopy images detecting H~2~S within live macrophage cells (Raw 264.7) using NanoBODIPY. C) 30 min incubation of cells and NanoBODIPY (top row) and 30 min incubation of the cells pretreated with 2.0 × 10^−6^ [m]{.smallcaps} fluvastatin (the CSE stimulator) for 48 h and NanoBODIPY (bottom row). D) 30 min incubation cells and NanoBODIPY followed by 100 × 10^−6^ [m]{.smallcaps} NaHS (top row) and 30 min incubation of the cells pretreated with 1 × 10^−3^ [m]{.smallcaps} DL‐propargylglycine (PAG, the CSE inhibitor) for 1 h along with 2.0 × 10^−6^ [m]{.smallcaps} fluvastatin (the CSE stimulator) for 48 h and NanoBODIPY (bottom row); ratio images were generated for the green channel (500--550 nm) relative to the red channel (560--650 nm). Reproduced with permission.[49](#advs1385-bib-0049){ref-type="ref"} Copyright 2016, American Chemical Society.](ADVS-6-1901724-g006){#advs1385-fig-0006}

4.2. LSPR Dark‐Field Imaging {#advs1385-sec-0110}
----------------------------

Plasmonic nanoparticles (PNPs), such as gold nanorods (AuNR), can provide extremely bright signal compared with organic fluorescent dyes.[130](#advs1385-bib-0130){ref-type="ref"}, [131](#advs1385-bib-0131){ref-type="ref"} By further coating Ag on the AuNR, Xiong et al. successfully applied the gold nanorod‐silver (AuNR‐Ag) core--shell PNPs for mapping H~2~S *n* living cells via dark‐field imaging.[41](#advs1385-bib-0041){ref-type="ref"} The AuNR‐Ag PNP (74 × 19 nm core and 2.1 nm shell) generated Ag~2~S and changed its LSPR wavelength when it encountered with H~2~S (**Figure** [**7**](#advs1385-fig-0007){ref-type="fig"}A,B). Notably, a linear logarithmic was observed between the spectral shifts and sulfide concentrations (ranging from 0.01 nm to 10 × 10^−6^ [m]{.smallcaps}) at various time points (1--30 min), indicating extremely high sensitivity. In addition, the AuNR‐Ag PNP demonstrated excellent H~2~S selectivity compared to other inorganic sulfur ions. Using this nanoplatform, the fluctuations of sulfide (0 × 10^−9^--100 × 10^−9^ [m]{.smallcaps}) and real‐time H~2~S mapping/calculation around single AuNR‐Ag PNP within live cells (from 5.8 × 10^−9^--41.8 × 10^−9^ [m]{.smallcaps} or 0.5 × 10^−9^--3.8 × 10^−9^ [m]{.smallcaps} for P1 or P2 respectively) was successfully achieved (Figure [7](#advs1385-fig-0007){ref-type="fig"}C--E).

![A) TEM and HR‐TEM images of AuNR‐Ag nanoprobes consisting of a AuNR core and Ag shell. B) The LSPR spectra of AuNR (green), AuNR‐Ag (purple), and AuNR‐Ag~2~S (red) nanoparticles via the experimental (left) and discrete dipole approximation (DDA) simulated approaches (right). The representative dark‐field images of two individual PNPs in different time points at C) 2 min, D) 26 min, and E) 42 min after the addition of 0.1 × 10^−3^ [m]{.smallcaps} Na~2~S into the HepG2 cells. The length of the scale bar is 10 mm. The individual PNPs are enlarged and presented in the inserted squares. Reproduced with permission.[41](#advs1385-bib-0041){ref-type="ref"} Copyright 2013, Nature Research.](ADVS-6-1901724-g007){#advs1385-fig-0007}

4.3. UCL Imaging {#advs1385-sec-0120}
----------------

Upconversion nanoparticles (UCNPs) convert continuous‐wave (CW) NIR wavelengths to visible light with a sizeable anti‐Stokes shift of several hundred nanometers.[132](#advs1385-bib-0132){ref-type="ref"}, [133](#advs1385-bib-0133){ref-type="ref"}, [134](#advs1385-bib-0134){ref-type="ref"}, [135](#advs1385-bib-0135){ref-type="ref"}, [136](#advs1385-bib-0136){ref-type="ref"}, [137](#advs1385-bib-0137){ref-type="ref"} Compared to organic dyes and inorganic semiconductor nanoparticles, UCNPs display superior features, such as scarcely autofluorescence from biological samples,[138](#advs1385-bib-0138){ref-type="ref"} a remarkable light penetration depth (up to 10 mm),[139](#advs1385-bib-0139){ref-type="ref"} no photobleaching in bioapplications,[140](#advs1385-bib-0140){ref-type="ref"}, [141](#advs1385-bib-0141){ref-type="ref"} and less damage to biological samples than UV excitation source.[142](#advs1385-bib-0142){ref-type="ref"} As a result, UCNPs are ideal probes for visualizing living cells and whole‐body animals.[143](#advs1385-bib-0143){ref-type="ref"}, [144](#advs1385-bib-0144){ref-type="ref"}, [145](#advs1385-bib-0145){ref-type="ref"} To achieve a sensing function, UCNPs need to combine with other chromophores with recognition sites, through the luminescence resonance energy transfer (LRET) process. Several UCNPs‐chromophores based LRET nanosystems have been developed for detecting critical biological species and toxins, such as DNA, O~2~, CN^−^, Hg^2+^, and Zn^2+^.[146](#advs1385-bib-0146){ref-type="ref"}, [147](#advs1385-bib-0147){ref-type="ref"}, [148](#advs1385-bib-0148){ref-type="ref"}, [149](#advs1385-bib-0149){ref-type="ref"}, [150](#advs1385-bib-0150){ref-type="ref"} In these applications, the UCNPs (donor) transfer energy to the organic chromophores (acceptor) and results in changes to the UCL emission. Thus, UCNPs^‐^chromophores are excellent candidates for H~2~S sensing probes.

Since the multicolor luminescence of UCNPs can be tuned by doping different ions, a series of chromophores with different absorption bands could be combined and designed for H~2~S‐specific response. For example, Peng et al. compared three H~2~S‐responsive chromophores combined with different doping ions UCNPs (NaYF~4~:Yb/Er/Tm, NaYF~4~:Yb/Er/Mn). This library of H~2~S sensors had responsive emission signals ranging from the visible to the NIR region.[34](#advs1385-bib-0034){ref-type="ref"} These UCNPs‐chromophores showed various LRET efficiency (11.8--25.1%), but all exhibited high excellent selectivity and rapid responsiveness in live cells and blood serum. Doping Tm^3+^ into UCNPs introduces UCL signals at 800 nm that can be utilized as an internal standard for ratiometric detection of H~2~S to improve sensitivity. As an example, Liu et al. employed NaYF~4~:20%Yb,2%Er,0.2%Tm\@mSiO~2~‐merocyanines for ratiometric detection of H~2~S using multiwavelength UCL.[151](#advs1385-bib-0151){ref-type="ref"} UCNPs\@mSiO~2~‐MC showed an enhanced ratiometric signal (*I* ~540~/*I* ~800~) for higher sensitivity with LOD at ≈0.58 × 10^−6^ [m]{.smallcaps}, which was lower than that of another merocyanine‐based H~2~S probe (1.0 × 10^−6^ [m]{.smallcaps}).[152](#advs1385-bib-0152){ref-type="ref"} Similarly, Zhou et al. used NaYF~4~:20%Yb,1.8%Er,0.5%Tm\@α‐cyclodextrin (CD)--coumarin hemicyanine (CHC1) dye as a ratiometric UCL probe (**Figure** [**8**](#advs1385-fig-0008){ref-type="fig"}A).[153](#advs1385-bib-0153){ref-type="ref"} By measuring the ratio of *I* ~580~/*I* ~800,~ this UCNPs was able to measure H~2~S concentrations as low as 0.13 µm, much more sensitive than single UCL signals (1.85 µm) in aqueous solution (Figure [8](#advs1385-fig-0008){ref-type="fig"}B). This UCNPs\@CD‐CHC1 could be used for ratiometric UCL monitoring of pseudo‐enzymatic H~2~S production in living cells, and also showed for ability to detect lipopolysaccharide (LPS)‐induced inflammation in the liver tissues of mouse models for the first time (Figure [8](#advs1385-fig-0008){ref-type="fig"}C).

![A) Schematic demonstrating the LRET process between the energy acceptor (CHC1) and energy donor (UCNPs). B) The change of CHC1‐UCNPs\' UCL emission patterns under a series of H~2~S concentrations (0 × 10^−6^--90 × 10^−6^ [m]{.smallcaps}), and the ratiometric values (*I* ~541~/*I* ~800~) along with optical image of green UCL emission are presented as inserted figure and photo. C) The UCL imaging of H~2~S expressed endogenously in mouse liver: a) the in vivo UCL imaging of the mice with inflammatory (for 24 h) after intravenous injection with CHC1‐UCNPs; b--d) The UCL images of liver section obtained from the mice injected with PBS and CHC1‐UCNPs only; e--g) The UCL images of liver section harvested from the mice administrated with LPS (20 mg kg^−1^) and CHC1‐UCNPs; h) The average UCL ratiometric values among different tissues. Images were acquired under an excitation 980 nm, with a green channel around 500--560 nm and red channel at 600--700 nm. Reproduced with permission.[153](#advs1385-bib-0153){ref-type="ref"} Copyright 2014, Wiley.](ADVS-6-1901724-g008){#advs1385-fig-0008}

UCNPs have also been developed for detecting or imaging of small molecules, biomacromolecules, organs, and tumors. Li et al. developed a merocyanine derivative modified UCNPs (NaYF~4~: 20%Yb, 2%Er, 0.2%Tm)\@PEG as a ratiometric UCL probe for H~2~S detection in mitochondria of live cells and live‐tissues (**Figure** [**9**](#advs1385-fig-0009){ref-type="fig"}A--C).[154](#advs1385-bib-0154){ref-type="ref"} This probe was used for locating the HCT116 (human colorectal cancer cell line) tumor in vivo by using NIR UCL imaging (Figure [9](#advs1385-fig-0009){ref-type="fig"}D--F). Additionally, this system was capable of monitoring mitochondrial H~2~S within tumor slices via a ratiometric UCL measurement (Figure [9](#advs1385-fig-0009){ref-type="fig"}G).

![A) Schematic of the cellular targeting process and mitochondrial H~2~S detection mediated by the TPAMC‐UCNPs\@PEG nanoplatform. B) Schematic of the LRET mechanism between UCNPs and TPAMC with or without H~2~S. C) The chemical structures of TPAMC and TPAMC‐SH. D) The UCL imaging obtained from HCT116 tumor‐bearing mice post‐intravenous administration of TPAMC‐UCNPs\@PEG. E) The ex vivo UCL images and F) the corresponding fluorescence quantifications of the major organs at 24 h post the TPAMC‐UCNPs\@PEG injection (*n* = 3). G) The two single channels and ratiometric UCL images of the tumor sections from the mice intravenously administrated with TPAMC‐UCNPs\@PEG and further injected with PBS (top raw) and S‐adenosyl‐[l]{.smallcaps}‐methionine (SAM) (button raw). The green (500--560 nm) and red (600--680 nm) signal of UCL were obtained under a 980 nm excitation. Reproduced with permission.[156](#advs1385-bib-0156){ref-type="ref"} Copyright 2018, American Chemical Society.](ADVS-6-1901724-g009){#advs1385-fig-0009}

To monitor H~2~S using UCL imaging both ex vivo and in vivo, Wang et al. proposed a PAA‐UCNPs (NaYF~4~:Yb/Tm\@NaYF~4~) loaded with a cyanine chromophore (Cy7‐Cl) as a NIR probe for H~2~S response. (**Figure** [**10**](#advs1385-fig-0010){ref-type="fig"}A).[155](#advs1385-bib-0155){ref-type="ref"} This nanoprobe was able to emit luminescence at 800 nm (Figure [10](#advs1385-fig-0010){ref-type="fig"}B,C) and demonstrated superb sensitivity toward H~2~S (Figure [10](#advs1385-fig-0010){ref-type="fig"}D,E). In addition to imaging exogenous and endogenous H~2~S in living cells (Hela and MCF‐7 cells), the Cy7‐UCNPs were successfully employed for sensing H~2~S in tumor‐bearing zebrafish in real time, with high penetration depth and low autofluorescence background (Figure [10](#advs1385-fig-0010){ref-type="fig"}F,G). Thus, the UCNPs‐chromophores were capable of monitoring H~2~S in living cells and small animals by UCL imaging. Ratiometric UCL‐based nanosystems provide a new design strategy for sensing and imaging of H~2~S that might be further utilized by novel probes for highly sensitive in vivo imaging studies.

![A) Schematic of luminescent strategy employed by PAA‐UCNPs, and the chemical structures of Cy7‐Cl and Cy7‐SH. B) The luminescence spectra of PAA‐UCNPs, Cy7‐UCNPs, and Cy7‐UCNPs + Na~2~S (50  × 10^−6^ [m]{.smallcaps}). C) The UV--vis absorption spectra of Cy7‐Cl (black) along with Cy7‐Cl + Na~2~S (blue), and the UCNPs\' luminescence spectrum (red). D) The change of luminescence spectra upon the addition of various Na~2~S concentrations (0 × 10^−6^--100  × 10^−6^ [m]{.smallcaps}). E) The enhancement of fluorescence ratio accompanied by increasing concentrations of Na~2~S. F) In vivo UCL images of exogenous and endogenous H~2~S in zebrafish via the Cy7‐UCNPs imaging system: a,b) normal zebrafish were injected with PBS, followed by an administration of Cy7‐UCNPs 30 min later; c,d) tumor‐bearing zebrafish was administrated with PBS, followed by an injection of Cy7‐UCNPs 30 min later; e,f) tumor‐bearing zebrafish was first injected with NMM (the scavenger of intracellular H~2~S), followed by an injection of Cy7‐UCNPs 30 min later; g,h) tumor‐bearing zebrafish was administrated with [l]{.smallcaps}‐Cys (the precursor of H~2~S), followed by the administration of Cy7‐UCNPs 30 min later; the length of scale bar is 500 µm. G) The corresponding average UCL intensities of data in (a,c,e,g). Reproduced with permission.[157](#advs1385-bib-0157){ref-type="ref"} Copyright 2018, Elsevier.](ADVS-6-1901724-g010){#advs1385-fig-0010}

4.4. NIR Imaging {#advs1385-sec-0130}
----------------

Various fluorescent probes have been successfully employed for detection of cellular H~2~S. However, most of these fluorescent probes emit in the ultraviolet or visible light region (450--750 nm that is impeded by cell autofluorescence. In contrast, long wavelength probes with emission in the NIR region are optimal for biological imaging applications due to minimal photodamage to biological samples and interference from background autofluorescence in living systems.[156](#advs1385-bib-0156){ref-type="ref"}, [157](#advs1385-bib-0157){ref-type="ref"} Additionally, NIR light (700--900 nm) can well improve the tissue depth penetration for in vivo imaging.[158](#advs1385-bib-0158){ref-type="ref"}, [159](#advs1385-bib-0159){ref-type="ref"} Among NIR fluorochromes, cyanine dyes have excellent photophysical properties, such as outstanding biocompatibility and low toxicity to living systems, which is suitable incorporation as a fluorescent probe.[159](#advs1385-bib-0159){ref-type="ref"}, [160](#advs1385-bib-0160){ref-type="ref"} For example, Wang et al. designed a NIR fluorescent cyanine probe Cy--NO~2~ (em. ≈789 nm) for H~2~S detection (via nitro group reduction) in aqueous solution and living cells.[161](#advs1385-bib-0161){ref-type="ref"} Similarly, Zhang et al. reported a cyanine‐based NIR probe (em. ≈796 nm) for a highly sensitive (with LOD at 39.6 × 10^−9^ [m]{.smallcaps}) and selective imaging of endogenous H~2~S in tissues and tumor models (HCT116 and HT29) of mice.[162](#advs1385-bib-0162){ref-type="ref"}

Recent progress has demonstrated that fluorescence imaging in the second near‐infrared window (NIR‐II, 1000--1700 nm) can further improve image contrast at increased tissue depths. Moreover, NIR‐II fluorescence imaging remarkably reduces interference from photon absorption and displays higher in vivo spatial resolution than NIR‐I imaging.[163](#advs1385-bib-0163){ref-type="ref"} Zhao\'s group fabricated an H~2~S‐triggered NIR‐II nanoprobe for visualizing colorectal cancers (**Figure** [**11**](#advs1385-fig-0011){ref-type="fig"}A).[164](#advs1385-bib-0164){ref-type="ref"} The nanoprobes were comprised of a silica shield and two organic chromophores, a boron‐dipyrromethene dye generating the NIR‐II emission (em. 900--1300 nm) with the presence of H~2~S and an inert aza‐BODIPY dye (em. 700 nm) as the internal reference (Figure [11](#advs1385-fig-0011){ref-type="fig"}B,C). The NIR‐II\@Si showed a selective identification of H~2~S rich colon cancer cells via a dual color imaging modality (Figure [11](#advs1385-fig-0011){ref-type="fig"}D,F,G). Moreover, NIR‐II\@Si was further explored for the H~2~S‐triggered NIR‐II imaging with the supporting of SAM (S‐adenosyl‐[l]{.smallcaps}‐methionine, the CBS activator) (HCT‐116 tumors), showing enhanced deep tissue penetration and spatial resolution (Figure [11](#advs1385-fig-0011){ref-type="fig"}E).[164](#advs1385-bib-0164){ref-type="ref"}

![A) Schematic of the formation of NIR‐II\@Si nanoprobe and the chemical structures of components including ZX‐NIR and NIRII‐HS. B) The variation of NIR‐II spectra of as‐prepared NIR‐II\@Si at different time points after the addition of 100 × 10^−3^ [m]{.smallcaps} NaHS, and the NIR‐II images of NIR‐II\@Si after H~2~S activation (10 mm ZXNIR) in the presence of 100 mm NaHS (inserted photo). C) The NIR‐I and NIR‐II fluorescent images of the H~2~S‐activated NIR‐II\@Si covered by pork skin with various thicknesses. The NIR‐I and NIR‐II imaging of the D) HCT116 tumor, G) HepG2 tumor, and F) normal tissue from tumor‐bearing mice or normal mice at different time points (5, 15, and 30 min) after intratumor or on‐site injection of NIR‐II\@Si nanoprobe. E) The NIR‐II images of HCT‐116 tumor‐bearing mice at 5, 15, and 30 min postinjection of NIR‐II\@Si nanoprobe along with AOAA (amino‐oxyacetic acid, the inhibitor) or SAM (S‐adenosyl‐[l]{.smallcaps}‐methionine, the activator). Reproduced with permission.[166](#advs1385-bib-0166){ref-type="ref"} Copyright 2018, Wiley.](ADVS-6-1901724-g011){#advs1385-fig-0011}

4.5. PA Imaging {#advs1385-sec-0140}
---------------

Among imaging methods that are not fluorescence‐based, PA imaging is a newly emerging technique. This modality is based on the PA effect of translation of excitation light into ultrasonic waves, which bridges the traditional depth and resolution limits of conventional optical imaging techniques.[165](#advs1385-bib-0165){ref-type="ref"}, [166](#advs1385-bib-0166){ref-type="ref"} As the acoustic waves are generated by pulsed laser light, noninvasive biomedical images with sharp optical absorption contrast and high ultrasonic resolution are produced.[167](#advs1385-bib-0167){ref-type="ref"}, [168](#advs1385-bib-0168){ref-type="ref"} The development of chemical PA probes proposed a new perspective for monitoring therapeutic response and real‐time molecular imaging.[169](#advs1385-bib-0169){ref-type="ref"}, [170](#advs1385-bib-0170){ref-type="ref"} For H~2~S detection, Shi et al. first presented a PA probe by encapsulating semi‐cyanine‐BODIPY hybrid dyes into the core--shell silica nanocomposites (Si\@BODPA), enabling real‐time imaging of H~2~S‐related biological processes (**Figure** [**12**](#advs1385-fig-0012){ref-type="fig"}A).[171](#advs1385-bib-0171){ref-type="ref"} Based on the thiol‐halogen nucleophilic substitution reaction, the Si\@BODPA produced emission at 780 nm after the hydrogen sulfide activation, leading to a 44‐fold turn‐on response within 15 s (Figure [12](#advs1385-fig-0012){ref-type="fig"}B,C). The LOD was determined to be as low as 53 × 10^−9^ [m]{.smallcaps}, a sufficient sensitivity for detecting endogenous H~2~S within living systems. Due to its rapid response, Si\@BODPA was then employed for the real‐time monitoring of endogenous H~2~S generation in HCT116 tumor‐bearing mouse to verify elevated level of H~2~S due to CBS upregulation (Figure [12](#advs1385-fig-0012){ref-type="fig"}D).

![A) Schematic of the Si\@BODPA nanoprobe. B) The change of absorbance of the Si\@BODPA1 along with Si\@BODPA2 with and without NaHS (100 × 10^−3^ [m]{.smallcaps}). C) The reaction times among BODPA2‐Si\@BODPA30 (13 min), BODPA2‐Si\@BODPA90 (6 min), BODPA1‐Si\@BODPA30 (5 min), BODPA1‐Si\@BODPA90 (2 min), BODPA1/2‐Si\@BODPA180/270 (within 15 s), and H~2~S (100 × 10^−3^ [m]{.smallcaps}). D) In vivo photoacoustic images of the mice bearing HCT‐116 tumor via the subcutaneously‐injected BODPA1‐Si\@BODPA180: a) the tumor regions with saline injection; b) the normal area with nanoprobe injection; c) the tumor regions with nanoprobe administration; d) the tumor area from the pretreated mice (100 nmol AOAA, 12 h in advanced) with nanoprobe administration; e) the tumor area from the pretreated mice (300 nmol SAM, 12 h in advanced) with nanoprobe injection; f) the corresponding PA intensities in a series of time points post BODPA1‐Si\@BODPA180 injection. Reproduced with permission.[173](#advs1385-bib-0173){ref-type="ref"} Copyright 2017, Royal Society of Chemistry.](ADVS-6-1901724-g012){#advs1385-fig-0012}

Ratiometric PA probes are able to further eliminate some of the shortcomings of a single responsive PA signal by self‐calibration. Thus, the combination of two PA responsive signals at two separated wavelengths would efficiently improve the accuracy of results. For example, Ma et al. developed a ratiometric photoacoustic nanoprobe AzHD (H~2~S‐responsive NIR dye) that was carried by a liposome for monitoring and imaging of H~2~S in cells, brain tissues, and live mice.[127](#advs1385-bib-0127){ref-type="ref"} With H~2~S‐mediated reduction of the azide, the AzHD‐LP absorption centered at 600 nm gradually decreased, and a new absorption band at 700 nm subsequently appeared (**Figure** [**13**](#advs1385-fig-0013){ref-type="fig"}A). Through this design, the ratio of PA700/PA532 increased about 4.5‐fold after reactive with H~2~S, which was about 23‐fold higher than a single PA signal alone (Figure [13](#advs1385-fig-0013){ref-type="fig"}B,C). The LOD of ratiometric PA signals was determined to be 91 × 10^−9^ [m]{.smallcaps}. This enabled the ratio of PA700/PA532 PA signal of healthy and Alzheimer\'s disease (AD) mice brains (homogenate supernatant) to increase by 6.5 and 1.2‐fold, respectively, following AzHD‐LP introduction (Figure [13](#advs1385-fig-0013){ref-type="fig"}D,E). Additionally, further conjugating the RGD targeting group to the AzHD‐LP allowed for successful monitoring of H~2~S in the HCT116 tumor‐bearing mice using time‐dependent dual‐channel ratiometric PA signals (Figure [13](#advs1385-fig-0013){ref-type="fig"}F--I). Therefore, the newly designed ratiometric PA probes of H~2~S sensing system provides a powerful analytical and imaging tool for further exploration of the roles of H~2~S in living complex organisms.

![A) Schematic of the ratiometric photoacoustic AzHD‐LP system, the change of the AzHD chemical structures, and PA absorbance (decrease of 532 nm and enhancement of 700 nm) after H~2~S exposure. B) The variation of two PA intensity (532 and 700 nm) of AzHD‐LP under different NaSH concentrations. C) The enhancement of PA700/PA532 ratio with increasing concentration of NaSH. D) The optical images of brain tissue from the normal mice and the mice with Alzheimer\'s Disease (AD). E) The plot of the PA700/PA532 ratio obtained from the AzHD‐LP after incubation with the brain homogenates from normal or AD mice. F) Schematic of the formation of RGD‐AzHD‐LP. G) The overlayed imaging of PA (PA700 and PA532) or ratiometric PA (PA700/PA532) with ultrasound acquired from the mice bearing subcutaneous HCT116 tumor. H) The corresponding quantitative intensity plot of PA532 (green) and PA700 (red) in (G). I) The ratiometric intensity of PA700/PA532 obtained from different groups at four hours post the intravenous administration of RGD‐AzHD‐LP: a) 12‐hour preinjection of PBS in the tumor area; b) 12‐hour preinjection of SAM (300 nmol) in the tumor area; c) 12‐hour preinjection of AOAA (100 nmol) in the tumor area; d) 12‐hour preinjection of ZnCl~2~ (H~2~S trapper) in the tumor area; the length of scale bar is 5 mm. Reproduced with permission.[129](#advs1385-bib-0129){ref-type="ref"} Copyright 2018, Royal Society of Chemistry.](ADVS-6-1901724-g013){#advs1385-fig-0013}

4.6. PET Imaging {#advs1385-sec-0150}
----------------

Although fluorescence‐based imaging techniques are primarily utilized for H~2~S detection, their applications in live‐animal imaging are limited because of the limited quantitative analysis. PET provides a highly sensitive non‐invasive technology for molecular imaging assays of metabolism, signal transduction, and gene expression from mice to patients.[172](#advs1385-bib-0172){ref-type="ref"}, [173](#advs1385-bib-0173){ref-type="ref"}, [174](#advs1385-bib-0174){ref-type="ref"} Unsurprisingly, targeted and sensitive PET probes have also been developed for H~2~S imaging. As an example, Yoo\'s group utilized ^64^CuS nanoparticles for the detection, quantification, and in vivo imaging of endogenous H~2~S via PET imaging.[128](#advs1385-bib-0128){ref-type="ref"} These nanoparticles were formed by twenty macrocyclic ^64^Cu complexes reacting with gaseous H~2~S to form insoluble ^64^CuS (**Figure** [**14**](#advs1385-fig-0014){ref-type="fig"}A). ^64^Cu‐cyclen showed high sensitivity (with a LOD at 0.15 µm) and selectivity for H~2~S over other potential competitors, including polysulfides. Due to the physical differences, the intravenously injected ^64^Cu‐cyclen and ^64^Cu‐cyclam were quickly cleared from the body, while the insoluble ^64^CuS nanoparticles were immobilized for more than 4 h after encountering H~2~S (Figure [14](#advs1385-fig-0014){ref-type="fig"}B). When ^64^Cu‐cyclen was administrated into mice intravenously, an elevated H~2~S concentration within the inflamed paw was visualized and quantified by both PET imaging and Cerenkov luminescence (Figure [14](#advs1385-fig-0014){ref-type="fig"}C,D). Moreover, the ^64^Cu‐cyclen could be also used to detect the defect site in the myocardium from an acute myocardial infarction (MI) model (Figure [14](#advs1385-fig-0014){ref-type="fig"}E--H). As such, this radioactive probe demonstrated great potential as a powerful nanoplatform providing efficient detection, accurate quantification, and nuclear imaging of H~2~S within living animals.

![A) Schematic of the formation of ^64^CuS via ^64^Cu--cyclen and H~2~S. B) The detection of H~2~S in vivo: a) Cerenkov luminescence images of the SD rats injected with Matrigel (top left), Matrigel + NaCl (top right), H~2~S gas dissolved in solution (bottom left) and NaHS (bottom right) respectively on the back at 0‐hour postinjection of ^64^Cu‐cyclen; b) The PET image of the injection site at 4 h postinjection ("L" stands for liver); c) The cerenkov luminescence images of SD rats injected with ^64^CuCl~2~ (top left), ^64^CuS (top right), ^64^Cu--cyclen (bottom left), and ^64^Cu--cyclam (bottom right) on the back at 0 h postinjection, and d) 4 h postinjection; e) The clearance of remained sample in a time pattern. C) The cerenkov luminescence images of BALB/c mice with paw inflammation (developed by complete Freund\'s adjuvant) at 1 h postinjection of various of probes; D) The PET (maximum intensity projection)‐CT images obtained from the BALB/c mice with paw inflammation at 1 h post‐administration of different probes. E) The transverse PET/CT images of the rats with acute myocardial infarction (MI) at 4 h postinjection of ^64^Cu---cyclen. F) The transverse PET/CT images of the rats with MI at 4 h postinjection of ^18^F‐FDG. G) The fused coregisterion image of ^64^Cu--cyclen and ^18^F‐FDG. H) The quantitative analysis of PET imaging of the MI models (*n* = 4). Reproduced with permission.[130](#advs1385-bib-0130){ref-type="ref"} Copyright 2016, Wiley.](ADVS-6-1901724-g014){#advs1385-fig-0014}

5. SHTS‐Based Nanomedicine for Disease Therapy {#advs1385-sec-0160}
==============================================

Following disease diagnosis, an effective, timely, and in situ treatment is highly demanded. In comparison to imaging agents, smart nanoplatforms could combine imaging, diagnosis, and therapy simultaneously. As highly‐expressed H~2~S within the disease area as a trigger, multifunctional nanoagents can serve as imaging and therapeutic agents simultaneously. As mentioned previously, the H~2~S functions as an important biological indicator and also has vital roles in a series of physiological functions, such as factors for protecting or killing cells. However, the application of most H~2~S donors is restricted by the short half‐life and low hydrophilic property. Due to these limitations, several H~2~S‐releasing nanomaterials were developed for various disease therapies. In this following section, these latest nanoagents designed for tumor diagnosis and treatment enabled by endogenous H~2~S activation will be discussed (**Table** [**4**](#advs1385-tbl-0004){ref-type="table"}). Additionally, the exogenous H~2~S delivering nanoplatforms employed for tumor therapy, ischemic/reperfusion protection, and transplanted organ preservation will be summarized.

###### 

Multifunctional nanoplatforms for SHTS‐based imaging and therapy

  Imaging strategy[^a)^](#advs1385-tbl4-note-0001){ref-type="fn"}    Material      Nanoparticles      Size \[nm\]      Therapeutic mechanism          Administration              Disease                            Ref.
  ----------------------------------------------------------------- ---------- --------------------- ------------- ----------------------------- ------------------------ ----------------------- -------------------------------------------
  FL                                                                   MOF      Cu~2~(ZnTcpp)·H~2~O       120              Photodynamic                Intratumoral          Colorectal cancer     [55](#advs1385-bib-0055){ref-type="ref"}
  NIR                                                                Polymer          Nano‐PT           8.4--15            Photothermal                Subcutaneous          Colorectal cancer     [175](#advs1385-bib-0175){ref-type="ref"}
  PA                                                                    Cu            Cu~2~O              21               Photothermal                Intravenous           Colorectal cancer     [54](#advs1385-bib-0054){ref-type="ref"}
  US/MRI                                                             Liposome           AML              ≈200            Bubble/H~2~S bomb             Intravenous         Hepatocellula cancer    [56](#advs1385-bib-0056){ref-type="ref"}
  N/A                                                                 Silica         DATS‐MSN          ≈225 ± 35    GSH triggered‐release H~2~S        Intravenous           Heart I/R injury      [176](#advs1385-bib-0176){ref-type="ref"}
                                                                                     DATS‐MSN          ≈225 ± 35    GSH triggered‐release H~2~S        Intravenous         Myocardial I/R Injury   [57](#advs1385-bib-0057){ref-type="ref"}
                                                                                     DATS‐MSN          175 ± 35     GSH triggered‐release H~2~S   Preoperative treatment            CAV            [177](#advs1385-bib-0177){ref-type="ref"}

I/R: Ischemic/reperfusion; US: Ultrasound; MRI: Magnetic resonance imaging; CAV: Cardiac allograft vasculopathy, MSN: Mesoporous silica nanoparticles.

John Wiley & Sons, Ltd.

5.1. Endogenous H~2~S‐Triggered Photodynamic Therapy {#advs1385-sec-0170}
----------------------------------------------------

Under a specific wavelength (e.g., near‐infrared light), photosensitizing agents generate reactive oxygen species (ROS) for treatment of diseases such as bacterial infection or cancers, referred to as photodynamic therapy (PDT).[178](#advs1385-bib-0178){ref-type="ref"}, [179](#advs1385-bib-0179){ref-type="ref"}, [180](#advs1385-bib-0180){ref-type="ref"} Compared with conventional therapies such as chemotherapy and radiotherapy, PDT is an ideal strategy to treat cancer (i.e., lead the cellular apoptosis and necrosis via the ROS activated) since it is noninvasive, safe, and convenient.[181](#advs1385-bib-0181){ref-type="ref"} However, photosensitizing agents (e.g., porphyrin) typically cannot elicit an antitumor PDT effect due to their physiochemical features (e.g., hydrophobic) nor are able to diagnose cancer. As such, nanomaterial alternatives have arisen as an attempt to effectively implement this therapeutic strategy. As an example, Ma et al. developed a smart, H~2~S‐triggered MOF nanosensor acted as a photosensitizer after exposure to H~2~S (**Figure** [**15**](#advs1385-fig-0015){ref-type="fig"}).[55](#advs1385-bib-0055){ref-type="ref"} This novel MOF, (Cu~2~(ZnTcpp)·H~2~O)*~n~* (NP‐1) was synthesized using a reverse microemulsion system followed by a hydrothermal treatment. NP‐1 reacted quickly with H~2~S within one minute to recover red fluorescence (≈Em610 and Em660). A linear logarithmic relationship was found for the fluorescence intensity and NaHS concentration (from 10--70 × 10^−6^ [m]{.smallcaps}) (Figure [15](#advs1385-fig-0015){ref-type="fig"}A,B). As a potential photosensitizer, the NP‐1 showed better PDT efficacy than the ZnTCPP precursor (Figure [15](#advs1385-fig-0015){ref-type="fig"}C). Specifically, NP‐1 (10 × 10^−6^ [m]{.smallcaps}) responded only to laser irradiation (600 nm) to generate ^1^O~2~ when H~2~S (50 × 10^−6^ [m]{.smallcaps}) was present. In comparison, when not irradiated or H~2~S was absent, NP‐1 was unable to damage to HepG2 human liver cancer cells (Figure [15](#advs1385-fig-0015){ref-type="fig"}C). After intratumoral injection and irradiation, NP‐1 was detrimental to the HCT‐116 cells (high H~2~S levels) and nearly eradicated the entire tumor (Figure [15](#advs1385-fig-0015){ref-type="fig"}D--G). Tumor shrinkage was also observed for mice injected with ZnTcpp following irradiation, but the therapeutic effect was relatively poor compared with NP‐1. The role of H~2~S in irradiation‐induced damage was confirmed using HCT‐116 cells (Figure [15](#advs1385-fig-0015){ref-type="fig"}H). Although this intelligent nanoplatform, NP‐1 shows significant potential as a H~2~S‐selective photosensitizing agent for PDT of cancer, further functionalization using PEGylation to enable the whole body circulation is highly recommended.

![A) The change of fluorescence spectra of NP‐1 after incubating with HS^−^ (0 × 10^−6^ to 10 × 10^−6^ [m]{.smallcaps}). B) The linear relationship between the fluorescence intensity of MOF NP‐1 and the NaHS\'s concentration. C) Confocal images obtained from the HepG2 cells with calcein‐AM and PI staining after the following treatments: a) 10 × 10^−3^ [m]{.smallcaps} MOF NP‐1; b) 10 × 10^−3^ [m]{.smallcaps} MOF NP‐1 + 50 × 10^−3^ [m]{.smallcaps} NaHS; c) 10 × 10^−3^ [m]{.smallcaps} MOF NP‐1 + irradiation; d) 10 × 10^−3^ [m]{.smallcaps} MOF NP‐1 + 50 × 10^−3^ [m]{.smallcaps} + irradiation. D) Optical images of the nude mice bearing HCT‐116 tumor with different treatments (before treatment, upper raw; after treatment, down raw): a) PBS administration; b) PBS injection followed by irradiation; c) ZnTcpp administration followed by irradiation; d) Cu(ZnTcpp) (MOF NP‐1) injection; e) Cu(ZnTcpp) injection followed by irradiation. E) The growth inhibition curve of tumor among different treatment groups. F) The body weight of mice from different therapy. G) Optical images of tumors extracted from MOF NP‐1 (upper row) and control (down raw) groups after irradiation. H) The MTT assay of the HCT116 cells treated with various concentrations of MOF NP‐1 with or without irradiation. Reproduced with permission.[55](#advs1385-bib-0055){ref-type="ref"} Copyright 2016, Wiley.](ADVS-6-1901724-g015){#advs1385-fig-0015}

5.2. Endogenous H~2~S‐Triggered Photothermal Therapy {#advs1385-sec-0180}
----------------------------------------------------

As an additional photodynamic treatment, photothermal therapy (PTT) can damage or kill cancer cells by generating vibrational energy in the form of heat after electromagnetic radiation.[37](#advs1385-bib-0037){ref-type="ref"}, [182](#advs1385-bib-0182){ref-type="ref"}, [183](#advs1385-bib-0183){ref-type="ref"}, [184](#advs1385-bib-0184){ref-type="ref"}, [185](#advs1385-bib-0185){ref-type="ref"} Many nanomaterials, including gold nanorods and graphene, have been employed as PTT photosensitizers using NIR excitation.[157](#advs1385-bib-0157){ref-type="ref"}, [186](#advs1385-bib-0186){ref-type="ref"} Nevertheless, the scatted nanoagent would cause further damage to surrounding normal tissues after a laser applied. Therefore, targeting or selective ability is strongly required. Recently, an innovative nanoagent (Nano‐PT) was synthesized via self‐assembly of a H~2~S activated small molecule that is consist of a hydrophilic tail and a BODIPY core (**Figure** [**16**](#advs1385-fig-0016){ref-type="fig"}A,B).[175](#advs1385-bib-0175){ref-type="ref"} As previously mentioned, the absorption wavelength of BODIPY changed after interaction with H~2~S. The variation (i.e., the change of wavelength from Ab540 to Ab790) enables the Nano‐PT to absorb NIR irradiation (785 nm laser, 5.37 W cm^−2^) and produce heat that can reach around 55° after 10 min of irradiation (Figure [16](#advs1385-fig-0016){ref-type="fig"}C). However, the temperature of the Nano‐PT solution only slightly increased when H~2~S was absent. After the introduction of H~2~S, a bright NIR‐II fluorescence signal (around Em950) was activated, and continuingly enhanced in a time‐dependent pattern, with a LOD value at 106 × 10^−9^ [m]{.smallcaps} (Figure [16](#advs1385-fig-0016){ref-type="fig"}D). With such effective sensitivity, the HCT‐116 tumor could be identified from normal tissue 2 h post the subcutaneous injection of Nano‐PT (Figure [16](#advs1385-fig-0016){ref-type="fig"}E). Importantly, a 20‐degree temperature difference between normal (41.8 °C) and tumor (60.9 °C) tissue could well prevent accidental injury of nearby tissue. Furthermore, PTT mediated by Nano‐PT successfully ablated the HCT‐116 tumor and limited any noticeable damage to the surrounding healthy tissue (Figure [16](#advs1385-fig-0016){ref-type="fig"}F,G).

![A) Schematic of Nano‐PT synthesis, the chemical structures of the components, and the transformation of SSS after the presence of H~2~S. B) Schematic illustration of the NIR‐II‐guided photothermal therapy for colorectal cancer mediated by Nano‐PT nanoplatform. C) The temperature curves of PBS, Nano‐PT, and Nano‐PT + NaHS (100 × 10^−6^ [m]{.smallcaps}) under laser irradiation. D) The change of NIR‐II fluorescence spectra of Nano‐PT during a series of time points (0--15 min) with NaHS (100 × 10^−6^ [m]{.smallcaps}), and the NIR‐II image of Nano‐PT after the H~2~S activation. E) The NIR‐II in vivo images of the normal and HCT‐116 tumor tissue on nude mice after on‐site subcutaneous injection of Nano‐PT at different time points. F) The ratios of tumor weight (*W* ~d15~/*W* ~d0~) among tumors collected from different groups (1) Control; 2) Nano‐PT; 3) Laser; 4) Nano‐PT + Laser) at day 15 and the corresponding photos of representative tumor tissues. G) The optical images of representative mice from different treated groups (1) Control; 2) Nano‐PT; 3) Laser; 4) Nano‐PT + Laser) at a series of time points; tumor sites has been indicated by red circles. Reproduced with permission.[177](#advs1385-bib-0177){ref-type="ref"} Copyright 2018, Wiley.](ADVS-6-1901724-g016){#advs1385-fig-0016}

By intratumorally or subcutaneously administration, these nanoplatforms are able to treat noticeable tumors with PDT and PTT. However, these strategies are limited for clinical applications that often require simultaneous diagnosis and therapy. To achieve this, Yang\'s lab recently designed a H~2~S activated nanomaterial, Cu~2~O (21 nm), for colon cancer (HCT‐116, CBS overexpression) theranostics (**Figure** [**17**](#advs1385-fig-0017){ref-type="fig"}A).[54](#advs1385-bib-0054){ref-type="ref"} After encountering endogenous H~2~S at the tumor site, Cu~2~O formed Cu~9~S~8~ which absorbed NIR irradiation (808 nm) and increased the tumor tissue temperature by 20.7 °C. Additionally, the formation of Cu~9~S~8~ provided a stable PA imaging agent that was unaffected by pH variations or GSH. For better efficiency, SAM (S‐adenosyl‐[l]{.smallcaps}‐methionine) or AOAA (amino‐oxyacetic acid) were administered by intravenous injection as a CBS activator and inhibitor, respectively. After supplementation of Cu~2~O with SAM, increased PA intensity was found at the tumor site (Figure [17](#advs1385-fig-0017){ref-type="fig"}B,C). While PA signal from Cu~2~O was detected, it failed to identify the tumor area due to its relatively lower intensity. Similarly, the CBS activator dramatically enhanced the temperature elevation with SAM + Cu~2~O treatment (15 °C), which was twice that of the Cu~2~O treated mice (Figure [17](#advs1385-fig-0017){ref-type="fig"}D,E). After two weeks of treatment with SAM + Cu~2~O and laser irradiation, HCT‐116 tumor‐bearing mice were completely eradicated (Figure [17](#advs1385-fig-0017){ref-type="fig"}F--H). In comparison, the size of the tumor treated with Cu~2~O + irradiation only slightly decreased. Thus, the reported Cu~2~O nanoparticle was an intelligent theranostic agent for clinic application after supplementation with SAM.

![A) The characterization of Cu~2~O and Cu~9~S~8~ nanoparticles: a) Schematic of the H~2~S‐induced transformation of Cu~2~O to Cu~9~S~8~; b) XRD patterns of the Cu~2~O and Cu~9~S~8~ nanoparticles; c,d) TEM images of the Cu~2~O and Cu~9~S~8~ nanoparticles; e,f) HR‐TEM images of the Cu~2~O and Cu~9~S~8~ nanoparticles; g,h) SAED patterns of the Cu~2~O and Cu~9~S~8~ nanoparticles. B) In vivo PA images of the mice bearing HCT‐116 tumor at various time points with different treatments. C) The corresponding PA intensities within the tumors. D) The in vivo thermal imaging of the mice carrying HCT‐116 tumor through a period of time after different treatments. E) The corresponding temperature change curve post 5 min irradiation. F) The optical images of representative mice bearing tumor from various therapeutic groups at day 16 posttreatment. G) The growth curve of tumor from different groups from 0 to 16 days. H) The representative tumor tissue harvested at day 16 postdifferent treatments. Reproduced with permission.[54](#advs1385-bib-0054){ref-type="ref"} Copyright 2018, Wiley.](ADVS-6-1901724-g017){#advs1385-fig-0017}

5.3. Nanoplatforms as Exogenous H~2~S Delivery System {#advs1385-sec-0190}
-----------------------------------------------------

Low concentrations of H~2~S are widely known to aid the proliferation of cancer cells and surrounding vessels.[4](#advs1385-bib-0004){ref-type="ref"}, [61](#advs1385-bib-0061){ref-type="ref"} However, sufficient H~2~S quickly released in tumor tissue affects cellular metabolism and has a toxic effect on tumor cells.[4](#advs1385-bib-0004){ref-type="ref"} Exploiting this, Liu et al designed a H~2~S‐generating "nanobomber" for cancer therapy (**Figure** [**18**](#advs1385-fig-0018){ref-type="fig"}A).[56](#advs1385-bib-0056){ref-type="ref"} This nanoliposomes (AML) was loaded with the H~2~S donors, anethole dithiolethione (ADT) and magnetic nanoparticles (MNPs), and had a diameter around 200 nm. The ADT could be activated enzymatically to continuingly release significant H~2~S gas, eventually forming microsized bubbles (Figure [18](#advs1385-fig-0018){ref-type="fig"}B). The H~2~S bubbles rapidly occupied most of the intracellular space and caused the apparent morphology changes,) which was strongly cytotoxic to HepG2 cells, with more than 40% death after 12 h (Figure [18](#advs1385-fig-0018){ref-type="fig"}C). These microbubbles were detected using ultrasonic imaging. After loading with MNPs, the AML accumulated in the tumor area under a magnetic field, which was around 3.4 times of that of Als (without MNPs) at 4 h postinjection (Figure [18](#advs1385-fig-0018){ref-type="fig"}D--F). Ultrasonic treatment was then applied was applied to burst the intratumoral microsized bubbles and subsequently induce physical damage and H~2~S‐induced cytotoxicity to the tumor tissue. The magnetic‐guided as therapy successfully induced cell apoptosis (with 21.5 ± 7.4%) and suppressed the tumor growth up to 7 days. However, treatment without the magnetic field showed relatively lower therapeutic effect and decreased apoptosis rates (15.4 ± 4.5%) (Figure [18](#advs1385-fig-0018){ref-type="fig"}G). In conclusion, this combined imaging system strongly enhanced the targeting accuracy during the treatment w will also providing the "H~2~S air bomber" for a novel cancer therapy strategy.

![A) Schematic of the combination tumor therapy mediated by the AMLs (anethole dithiolethione (ADT)‐loaded magnetic nanoliposome) nanoplatform. B) The optical images of the cellular morphology change and the bubble generated inside at 12 and 24 h after the incubation with AMLs (upper raw), ALs (middle raw), and liposomes (down raw) respectively; the generated bubbles and the serious membrane disruption have been indicated by red arrows. C) The HepG2 cell viability after the incubations with various samples for different time periods; the statistical difference is shown by \*\**p* \< 0.01 and \**p* \< 0.05. D) The in vivo ultrasonic and E) T2 MR imaging of the HepG2 tumor area at 12 and 24 h post the injections of AMLs (upper raw), ALs (middle raw), and liposomes (down raw). F) The DiR‐fluorescence images of a HepG2 bearing mice with the injection of DiR‐AMLs under external magnetic field (down raw) or no (upper raw) at 12 and 24 h. G) The TUNEL assay on tumor tissue obtained. Scale bars = 20 µm. Reproduced with permission.[56](#advs1385-bib-0056){ref-type="ref"} Copyright 2017, American Chemical Society.](ADVS-6-1901724-g018){#advs1385-fig-0018}

Supplementation of H~2~S can help preserve organs and protect injuries triggered by ischemia/reperfusion by various antiapoptotic, antiinflammatory and antioxidative methods.[187](#advs1385-bib-0187){ref-type="ref"}, [188](#advs1385-bib-0188){ref-type="ref"}, [189](#advs1385-bib-0189){ref-type="ref"} However, most H~2~S donors cannot produce decent protection due to burst release and poor solubility, such as the NaHS or diallyl sulfide (DATS). Mesoporous silica nanoparticles (MSNs) have arisen as ideal nanoplatforms due to their large surface area that can be diversely functionalized, adjustable pore size for loading various cargo (e.g., the hydrophobic drug), and overall biocompatibility.[190](#advs1385-bib-0190){ref-type="ref"}, [191](#advs1385-bib-0191){ref-type="ref"} Recently, Wang\'s lab successfully developed DATS‐loaded MSNs as a H~2~S‐generating platform for protecting organs from I/R injury and transplantation.[57](#advs1385-bib-0057){ref-type="ref"}, [176](#advs1385-bib-0176){ref-type="ref"}, [177](#advs1385-bib-0177){ref-type="ref"} These MSN (175--225 nm) efficiently carried DATS at the surface pore (≈2 nm) because of the high affinity between DATS and Si‐OH, with an entrapment rate around 99% (**Figure** [**19**](#advs1385-fig-0019){ref-type="fig"}A).[176](#advs1385-bib-0176){ref-type="ref"} A sustained DATS release profile (reaching about 80 min) was achieved after loaded on MSN and in the presence of GSH in the solution. In turn, the amount of H~2~S released from DATS alone quickly declined after only one hour. The supplementation of DATS‐MSN in the preserving solution effectively reduced inflammation in the transplanted organ by downregulating the expression level of intercellular adhesion molecule‐1 (ICAM‐1) and vascular cell adhesion molecule‐1 (VACM‐1).[177](#advs1385-bib-0177){ref-type="ref"} Notably, the DATS‐MSN continuingly released H~2~S into the plasma for up to 12 h, while NaHS and DATS quickly decreased after one or three hours respectively (Figure [19](#advs1385-fig-0019){ref-type="fig"}B).[57](#advs1385-bib-0057){ref-type="ref"} The administration of DATS‐MSN reduced myocardial apoptosis by approximately 15% at 24 h post‐reperfusion. Additionally, DATS‐MSN and substantially decreased I/R injury in myocardial tissues, which was confirmed using TTC staining (percentage of infarction area (INF)/area at risk (AAR)) (Figure [19](#advs1385-fig-0019){ref-type="fig"}C,D). More importantly, the DATS‐MSN exhibited superior protection of the heart after I/R injury in comparison to GYY4137, a conventional H~2~S donor with slow release kinetics (Figure [19](#advs1385-fig-0019){ref-type="fig"}E,F).

![A) Schematic of a GSH‐mediated DATS‐MSN nanoplatform for sustained release of H~2~S. B) The curve of H~2~S concentrations in the mice plasma from different groups overtimes. C) The apoptosis rate of cardiomyocytes after the myocardial ischemia/reperfusion (I/R) injury, which is shown by positive cell percentage in the TUNEL staining. D) The representative photographs of mid‐myocardial cross sections with TTC staining at 72 h post I/R injury. E) The concentration of H~2~S within the plasma from GYY4137 or DATS‐MSN treated groups during the 12 h after I/R injury. F) H~2~S concentrations in the plasma and myocardium from GYY4137 or DATS‐MSN treated mice at 72 h after I/R injury. Reproduced with permission.[57](#advs1385-bib-0057){ref-type="ref"} Copyright 2017, Nature Research.](ADVS-6-1901724-g019){#advs1385-fig-0019}

6. Conclusion and Future Outlook {#advs1385-sec-0200}
================================

Undoubtedly, early diagnosis significantly contributes to attaining successful therapeutic interventions.[192](#advs1385-bib-0192){ref-type="ref"} Early diagnosis---especially for cancer---is likely to increase the efficacy of nearly every therapy, ranging from surgery, chemotherapy, radiotherapy to immunotherapy. In addition screening specific diseases\' biomarkers (e.g., tumor surface markers), proper surveillance of the influential gasotransmitters would effectively aid disease diagnosis at early stages.[193](#advs1385-bib-0193){ref-type="ref"} Of these, H~2~S is vitally important in a series of signaling pathways associated with various physiological (e.g., antiinflammation and antiapoptosis) and pathological effects (e.g., tumor progress, etc.).[194](#advs1385-bib-0194){ref-type="ref"} Additionally, the high toxicity of H~2~S further emphasizes the importance of monitoring H~2~S, especially for potential air exposures. Currently, several organic probes have been implemented for detecting/imaging H~2~S. However, widespread applicability is restricted by their poor physiochemical conditions, including relatively weak sensitivity and limited circulation.[13](#advs1385-bib-0013){ref-type="ref"}, [14](#advs1385-bib-0014){ref-type="ref"}

Advanced nanomaterials have demonstrated desirable properties as multifunctional platforms for imaging and therapy.[49](#advs1385-bib-0049){ref-type="ref"}, [195](#advs1385-bib-0195){ref-type="ref"} In recent years, nanomaterials have been continually developed as novel probes for H~2~S‐triggered detection, imaging, and therapy (Figure [1](#advs1385-fig-0001){ref-type="fig"}). This review summarizes and discusses all SHTS‐based nanomedicines to date, focusing on H~2~S imaging of cancer cells and in tumor‐bearing mice as well as for disease therapy (e.g., cancer or I/R injury) (**Table** [**5**](#advs1385-tbl-0005){ref-type="table"}). More specifically, various H~2~S imaging approaches using fluorescence, LSPR, UCL, NIR, PA, and PET modalities are summarized. Therapeutic strategies, such as photodynamic and photothermal therapy, influenced by the presences of H~2~S are also discussed in detail. To provide more ideas for the H~2~S related treatments, the H~2~S generated nanoplatforms have been included as well. Undeniably, the development of SHTS‐based nanomedicine has seen much progress accelerated by the efforts of researchers. However, there are still several principles and challenges that need to be addressed in future H~2~S‐nanoprobe designs. Below we provide a series of considerations regarding these crucial issues for future SHTS‐base nanomedicine innovation and translation (**Figure** [**20**](#advs1385-fig-0020){ref-type="fig"}).

###### 

The nanoagents involved in SHTS

<table><thead><tr class="header"><th style="text-align: left;">Material<a href="#advs1385-tbl5-note-0001" data-ref-type="fn"><sup>a)</sup></a></th><th style="text-align: center;">In vitro detection/imaging</th><th style="text-align: center;">In vivo imaging</th><th style="text-align: center;">Therapy</th><th style="text-align: center;">Number of Application</th><th style="text-align: center;">Features</th><th style="text-align: center;"></th><th style="text-align: center;"></th><th style="text-align: center;"></th><th style="text-align: center;"></th><th style="text-align: center;"></th><th style="text-align: center;"></th></tr></thead><tbody><tr class="odd"><td style="text-align: left;">NMNCs/NPs</td><td style="text-align: center;">✓✓</td><td style="text-align: center;"></td><td style="text-align: center;">✓</td><td style="text-align: center;">DFI</td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;">19</td><td style="text-align: center;">0</td><td style="text-align: center;"><p>Limited imaging depth;</p><p>In vitro detection only;</p><p>Expensive</p></td><td style="text-align: center;"><p>High sensitivity;</p><p>Direct reaction with H<sub>2</sub>S;</p><p>Eye‐visible detection;</p><p>Reusability</p></td></tr><tr class="even"><td style="text-align: left;">C‐dot</td><td style="text-align: center;"></td><td style="text-align: center;">✓</td><td style="text-align: center;">✓</td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;">7</td><td style="text-align: center;">0</td><td style="text-align: center;"><p>Limited imaging depth;</p><p>In vitro detection only</p></td><td style="text-align: center;"><p>High biocompatibility;</p><p>Affordable and reproducible preparation</p></td></tr><tr class="odd"><td style="text-align: left;">Cu</td><td style="text-align: center;"></td><td style="text-align: center;">✓✓</td><td style="text-align: center;">✓</td><td style="text-align: center;"></td><td style="text-align: center;">PET</td><td style="text-align: center;">PT</td><td style="text-align: center;"></td><td style="text-align: center;">7</td><td style="text-align: center;">2</td><td style="text-align: center;">Low biocompatibility</td><td style="text-align: center;"><p>Quick and direct reaction with H<sub>2</sub>S;</p><p>Gas detection</p></td></tr><tr class="even"><td style="text-align: left;">Silica</td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;">✓</td><td style="text-align: center;"></td><td style="text-align: center;">NIR/PA</td><td style="text-align: center;"></td><td style="text-align: center;">✓</td><td style="text-align: center;">1</td><td style="text-align: center;">5</td><td style="text-align: center;"><p>Relatively high cytotoxicity;</p><p>Limited circulation</p></td><td style="text-align: center;"><p>Easy functionalization;</p><p>Strong capability in drug loading</p></td></tr><tr class="odd"><td style="text-align: left;">LNPs/PMNs</td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;">✓</td><td style="text-align: center;"></td><td style="text-align: center;">NIR/US/MRI</td><td style="text-align: center;">PT/BB</td><td style="text-align: center;"></td><td style="text-align: center;">0</td><td style="text-align: center;">3</td><td style="text-align: center;">Relatively low stability</td><td style="text-align: center;">Desirable biocompatibility and circulation</td></tr><tr class="even"><td style="text-align: left;">MOF</td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;">✓</td><td style="text-align: center;"></td><td style="text-align: center;">FL</td><td style="text-align: center;">PD</td><td style="text-align: center;"></td><td style="text-align: center;">8</td><td style="text-align: center;">1</td><td style="text-align: center;"><p>Limited circulation;</p><p>Relatively large size;</p><p>Poor in vivo imaging (FL)</p></td><td style="text-align: center;"><p>Large surface area for modification;</p><p>Direct reaction with H<sub>2</sub>S via the cation carried</p></td></tr><tr class="odd"><td style="text-align: left;">UCNPs</td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;">UCL</td><td style="text-align: center;">UCL</td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;">2</td><td style="text-align: center;">3</td><td style="text-align: center;">Relatively high cytotoxicity</td><td style="text-align: center;"><p>Desirable imaging penetration;</p><p>Consistent imaging reference for calibration</p></td></tr></tbody></table>

NMNCs/NPs: Noble metal nanoclusters/nanoparticles; CM: Colorimetry; EC: Electrochemistry; FL: Fluorescence; DFI: Dark field imaging; UCL: Upconversion luminescence; NIR: Near infrared; PA: photoacoustic imaging; PET: positron emission tomography; PD: Photodynamic; PT: Photothermal; BB: Bubble bomb.
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![The current status and barriers that need to be overcome for future development of smart H~2~S‐triggered/therapeutic system (SHTS).](ADVS-6-1901724-g020){#advs1385-fig-0020}

6.1. Challenge {#advs1385-sec-0210}
--------------

Due to physiochemical properties, H~2~S quickly dissolves in water and results in the formation of HS^−^ and S^2−^ that introduce interference. Additionally, toxic H~2~S generated from cells is processed rapidly by anabolism and catabolism. Due to this dynamic nature, real‐time imaging of H~2~S is highly demanded to inform the location/status of disease (e.g., cancer) following therapy. In summary, a specific, sensitive, and multifunctional H~2~S sensor with excellent circulation (for reaching the specific area) is ideal for H~2~S detection and therapy.

6.2. Influence of Size, Shape, and Charge {#advs1385-sec-0220}
-----------------------------------------

The morphology of nanomaterials, especially size, directly affects the optical features (e.g., LSPR) and contacting area. Both of these aspects are strongly related to the sensitivity toward H~2~S. Additionally, large nanoparticle (\>200 nm) tend to absorb more serum proteins (34% absorbance) compared with smaller ones (80 nm, with 6% absorbance). This results in only smaller nanoparticles having a circulation half‐life suitable for imaging.[196](#advs1385-bib-0196){ref-type="ref"} Additionally, the nanomaterials biodistribution is significantly affected by their shape and surface charge.[197](#advs1385-bib-0197){ref-type="ref"}, [198](#advs1385-bib-0198){ref-type="ref"}, [199](#advs1385-bib-0199){ref-type="ref"} For instance, tumor tissue accumulation is enhanced with negatively charged NPs.[198](#advs1385-bib-0198){ref-type="ref"}, [199](#advs1385-bib-0199){ref-type="ref"} Thus, varying the diameter, shape, and charge alter biodistribution and tumor penetration and subsequently influence the efficiency of imaging and therapy.[200](#advs1385-bib-0200){ref-type="ref"}, [201](#advs1385-bib-0201){ref-type="ref"}

6.3. Surface Modification {#advs1385-sec-0230}
-------------------------

Although the H~2~S detection (e.g., solution, serum or H~2~S in the air) can be performed with unmodified nanomaterials, surface modifications (e.g., PEGlaytion, acetylation, amino acid or ligand/antibody functionalization) greatly increase their stability, biocompatibility, circulation and targeting for in vivo sensing/delivery.[202](#advs1385-bib-0202){ref-type="ref"}, [203](#advs1385-bib-0203){ref-type="ref"} Other surface modifications of functional groups or material (e.g., Cyclam‐Cu^2+^ or FRET acceptor)[45](#advs1385-bib-0045){ref-type="ref"}, [122](#advs1385-bib-0122){ref-type="ref"} can impart an alternative strategy that affords a specific nanomaterial (such as Au nanorod with photothermal strategy) with H~2~S‐selectivity.

6.4. Accuracy of Real‐Time H~2~S Concentration {#advs1385-sec-0240}
----------------------------------------------

During in vivo imaging, interfering background signal from tissue autofluorescence (e.g., skin) greatly affects H~2~S visualization. Although most in vivo NIR or PET imaging agents limit the autofluorescence background, the accuracy of H~2~S detection or imaging would be further influenced by the variation among individuals. As an ideal imaging system, UCNPs can greatly reduce autofluorescence. Additionally, the unique ratiometric strategy applied (i.e., the ratio of specific emission/a control emission) ensure sensing accuracy. Thus, we believe the incorporation of a reference emission using surface modification or reagent loading will increase imaging accuracy during diagnosis and therapy.

6.5. Sensitivity Enhancement for In Vivo Imaging {#advs1385-sec-0250}
------------------------------------------------

As mentioned above, the biological half‐life of H~2~S is short. Typically, biological concentrations are generally lower than the LOD of most nanoagents. To improve the detection performance, an enhancement (*e.g*, SAM) agent is strongly recommended, especially for H~2~S‐triggered therapeutic nanoplatforms.[54](#advs1385-bib-0054){ref-type="ref"}

6.6. Therapeutic Strategy {#advs1385-sec-0260}
-------------------------

A series of combined therapies including photodynamic, photothermal, and gas‐generated treatments, have been listed in this review. These smart nanoplatforms are all H~2~S‐regulated and mitigate damage to surrounding tissue. However, the potential problems, including the releasing speed and the concentration of H~2~S generated within a certain area, must be controlled. Meanwhile, additional agents, such as chemical drugs or vaccine adjuvants (e.g., CpG ODN) could be further loaded for combined chemotherapy or immunotherapy after H~2~S activation.

6.7. Applications and Selection of Nanosensor {#advs1385-sec-0270}
---------------------------------------------

Given diverse applications for SHTS‐based nanomedicine, proper nanoplatform selection is critical. For the detection of H~2~S in solution, biosample, and air, the priority of nanosensor selection is the selective, sensitivity, and practicality. For instance, the sensors with a physical supporting (e.g., supporting membrane) or an eye‐visible colorimetric examination would be more practical and convenient. Alternatively, biocompatibility and circulation half‐life are the key factors for in vivo imaging and therapy. Although great progress has been made in the development of nanomaterials as H~2~S sensors with high sensitivity and selectivity, only a few can apply in the in vivo assay due to the bad biocompatibility and circulation. Thus, to promote the real application of SHTS based nanomedicine and its following clinic translation, more efforts should be dedicated to investigating these aspects.

In a sharp comparison of general strategies, the advances of nanotechnology enable us to combine various functions into one nanoagent. With SHTS‐based nanomedicine, we are able to detect and imaging H~2~S for different applications, and also induce specific therapy following the diagnosis. The increasing interest in real‐time H~2~S imaging and high performance of SHTS would encourage the further investigation of the following translation in the clinic, which will greatly improve the diagnosis of various H~2~S diagnosis and benefit the patients via a safe and efficient therapeutic strategy.
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